Abyzov, Alexej |
Mayo Clinic Rochester
United States |
Detection of somatic, subclonal and mosaic CNVs from sequencing |
5U24CA220242-05 |
|
Christos Patriotis, Ph.D., M.Sc. |
Kingham, T Peter |
Sloan-Kettering Inst Can Research
United States |
Point of care, real-time urine metabolomics test to diagnose colorectal cancers and polyps in low- and middle-income countries |
5UH3CA257869-05 |
|
Matthew Young, Ph.D. |
Mcdonald, Andrew M |
University Of Alabama At Birmingham
United States |
A Randomized Phase II Trial of Flibanserin in Men Receiving Androgen Suppression for Prostate Cancer |
5R21CA259808-02 |
|
Howard L. Parnes, M.D. |
Robien, Kimberly Z |
George Washington University
United States |
Body composition and chemotherapy toxicity among women being treated for breast cancer |
5R21CA259790-02 |
|
Sharon Ross, Ph.D., M.P.H. |
Zhou, Chuan |
University Of Michigan At Ann Arbor
United States |
Histopathology correlated quantitative analysis of lung nodules with LDCT for early detection of lung cancer |
5U01CA216459-05 |
PAR-16-089 (U01) |
Guillermo Marquez, Ph.D. |
Crott, Jimmy W |
Boston University Medical Campus
United States |
Identifying the active factor of an anti-inflammatory chemopreventive bacterium |
7R21CA253392-02 |
|
Young Kim, Ph.D. |
Taratula, Oleh |
Oregon State University
United States |
Novel Nanomedicine-Based Therapeutic Approach For Treatment of Cancer Cachexia |
5R37CA234006-05 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
Findlay, Victoria Jane |
Virginia Commonwealth University
United States |
The effects of time restricted feeding on AGE-RAGE signaling in women at high risk for breast cancer |
7R21CA258139-02 |
|
Edward Sauter, M.D., Ph.D. |
Agarwal, Rajesh |
University Of Colorado Denver
United States |
Skin Cancer Chemoprevention by Silibinin: Mechanisms and Efficacy |
3R01CA140368-10S1 |
PA-20-227 (Admin Supp-Clinical Trial Not Allowed) |
Amit Kumar, Ph.D. |
Buchanan, Adam H |
Geisinger Clinic
United States |
Feasibility and Assessment of a Cascade Traceback Screening program - FACTS |
5U01CA240747-04 |
PAR-18-616 (U01 Clinical Trial Optional) |
|
Chen, Ru |
Baylor College Of Medicine
United States |
Biomarkers for Early Detection of Colorectal Cancer in Ulcerative Colitis |
5R01CA211892-06 |
|
Matthew Young, Ph.D. |
Jim, Heather S.L. |
H. Lee Moffitt Cancer Ctr & Res Inst
United States |
Randomized Placebo Controlled Trial of Bupropion for Cancer Related Fatigue |
5R01CA214647-05 |
|
Marge Good, R.N., M.P.H., O.C.N. |
Augenlicht, Leonard H |
Albert Einstein College Of Medicine
United States |
A Major Nutritional Effect on Intestinal Stem Cells and Tumors |
5R01CA214625-06 |
|
Nancy J. Emenaker, Ph.D., R.D.N., L.D., F.A.N.D. |
Wu, Xiangwei |
University Of Tx Md Anderson Can Ctr
United States |
Activating p53 for colorectal cancer prevention |
5R01CA214954-06 |
|
|
Chauhan, Subhash C. |
University Of Texas Rio Grande Valley
United States |
MUC13 Mucin in Colerectal Cancer Health Disparity |
5R01CA204552-05 |
|
Matthew Young, Ph.D. |
Augenlicht, Leonard H |
Albert Einstein College Of Medicine
United States |
Genetic and Dietary Interactions in MMR Deficient Colon Tumorigenesis |
5R01CA222358-06 |
|
Nancy J. Emenaker, Ph.D., R.D.N., L.D., F.A.N.D. |
Augenlicht, Leonard H |
Albert Einstein College Of Medicine
United States |
Nutritionally Driven Sporadic Intestinal Tumors: Impact on Stem Cells |
5R01CA229216-06 |
|
Nancy J. Emenaker, Ph.D., R.D.N., L.D., F.A.N.D. |
Nautiyal, Shivani |
Prime Genomics, Inc.
United States |
Device for Preservation of Cell Free RNA in Saliva |
5R21CA258013-02 |
|
Guillermo Marquez, Ph.D. |
Arcaro, Kathleen Frances |
University Of Massachusetts Amherst
United States |
Fruit and vegetable intervention in lactating women to reduce breast cancer risk: effects on breast cell DNA methylation, breast inflammation, and weight |
5R01CA230478-05 |
|
|
Abrams, Julian |
Columbia University Health Sciences
United States |
The Oral Microbiome for the Detection of Barretts Esophagus |
5R01CA238433-05 |
|
|
Brennan, Paul Joseph |
International Agency For Res On Cancer
United States |
PROMINENT - IARC |
3OT2CA278681-01S1 |
|
|
Balmain, Allan |
University Of California, San Francisco
United States |
PROMINENT - UCSF |
3OT2CA278665-01S1 |
|
|
Counter, Christopher M |
Duke University
United States |
PROMINENT-DUKE |
3OT2CA278661-01S1 |
|
|
Lopez-Bigas, Nuria |
Fundacio Institut De Recerca Biomedica
United States |
PROMINENT - IRB |
3OT2CA278668-01S1 |
|
|
Lundberg, Emma |
Stanford University
United States |
PROMINENT - Stanford |
3OT2CA278713-01S1 |
|
|
Gunter, Marc James |
Imperial College Of Science, Technology And Medicine
United States |
PROMINENT: Discovering the molecular signatures of cancer PROMotion to INform prevENTion |
1OT2CA290880-01 |
|
|
Conley, Yvette P |
University Of Pittsburgh At Pittsburgh
United States |
Epigenomics of Neurocognitive Function in Breast Cancer |
5R01CA221882-05 |
|
|
Wen, Kuang-Yi |
Thomas Jefferson University
United States |
A Mobile TXT-based Intervention to Improve Adherence to Adjuvant Hormone Therapy and Symptom Management for BCa Survivors |
5R01CA222246-05 |
|
|
Hinds, Pamela S |
Children'S Research Institute
United States |
Longitudinal, multimodal assessment of neuropsychological functioning in children diagnosed with high-risk acute lymphoblastic leukemia (HR-ALL): Using early changes to predict later impairment |
5R01CA212190-05 |
|
|
Soragni, Alice |
University Of California Los Angeles
United States |
Targeting p53 conformational defects to arrest carcinogenesis |
5R01CA240718-05 |
|
|
Stolley, Melinda R |
Medical College Of Wisconsin
United States |
Men Moving Forward: A Lifestyle Intervention for African American Prostate Cancer Survivors |
3R01CA229546-05S1 |
|
Sharon Ross, Ph.D., M.P.H. |
Valdez, Erin G |
Stanford University
United States |
Circadian regulation of cancer therapy-associated neuroinflammation |
5R21CA267135-02 |
PAR-20-292 (R21 Clinical Trial Optional) |
|
Paulson, Thomas G |
Fred Hutchinson Cancer Center
United States |
The microbiome ecosystem of Barrett's esophagus and progression to cancer |
5R21CA259687-02 |
PAR-20-292 (R21 Clinical Trial Optional) |
|
Kober, Kord Michael |
University Of California, San Francisco
United States |
An Evaluation of Cloud Computing for Symptom Science Research: Moving Genomics and Machine Learning Analyses of Cancer Chemotherapy-Related Fatigue to the Cloud |
3R37CA233774-05S1 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
Fortier, Michelle |
University Of California-Irvine
United States |
Innovative Pain and Symptom Management Program for Children with Cancer |
3R01CA222012-05S1 |
|
|
Kupfer, Sonia |
University Of Chicago
United States |
Colonic responses to vitamin D and aspirin in African- and European-Americans |
5R01CA220329-05 |
|
Gabriela Riscuta, M.D., C.N.S. |
Turesky, Robert J. |
University Of Minnesota
United States |
DNA adductomics of the urinary system |
5R01CA220367-06 |
|
Wendy Wang, Ph.D., M.Sc. |
Oskeritzian, Carole A |
University Of South Carolina At Columbia
United States |
Development of a noninvasive, rapid and affordable method for early detection of colorectal cancer |
5R21CA245651-03 |
|
Matthew Young, Ph.D. |
Permuth, Jennifer B. |
H. Lee Moffitt Cancer Ctr & Res Inst
United States |
Using Radiogenomics to Noninvasively Predict the Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Uncover Hidden Biology |
5R37CA229810-05 |
|
|
Dantzer, Robert |
University Of Tx Md Anderson Can Ctr
United States |
The Metabolic Basis of Cancer-Related Fatigue |
5R01CA193522-09 |
|
|
Bissonnette, Bruce Marc |
University Of Chicago
United States |
CXCR4 as a target for colon cancer chemoprevention |
5R01CA240710-05 |
|
|
Heinrich, Michael C |
Oregon Health & Science University
United States |
Novel models for functional profiling of germline SDH variants associated with cancer |
5R21CA263400-02 |
PAR-20-292 (R21 Clinical Trial Optional) |
Richard Mazurchuk, Ph.D. |
Chang, Su-Hsin |
Washington University
United States |
Addressing racial disparities in monoclonal gammopathy of undetermined significance and progression to multiple myeloma from a prevention perspective |
5R01CA253475-03 |
|
Asad Umar, D.V.M., Ph.D. |
Wu, Bechien |
Kaiser Foundation Research Institute
United States |
PRedictiOn Algorithms for the DeTECTion of Early Stage Pancreatic Cancer (PRO-TECT) |
5R01CA230442-05 |
|
|
Maitra, Anirban |
University Of Tx Md Anderson Can Ctr
United States |
Longitudinal therapeutic monitoring of colorectal cancer patients using exosome-based liquid biopsies |
5R01CA218230-05 |
PAR-16-276 (R01) |
Matthew Young, Ph.D. |
Mao, Jun J |
Sloan-Kettering Inst Can Research
United States |
Dopamine Metabolism and Nonpharmacologic Insomnia Interventions Among Cancer Survivors |
5R21CA274059-02 |
|
|
Kuhs, Krystle A. |
University Of Kentucky
United States |
Circulating HPV DNA as a Prediagnostic Marker of Oropharyngeal Cancer |
5R21CA267152-02 |
|
|
Goldman, Radoslav |
Georgetown University
United States |
O-glycoproteins in the progression of liver disease |
5R01CA238455-05 |
|
|
Kalluri, Raghu |
University Of Tx Md Anderson Can Ctr
United States |
Rigorous and reproducible mutational analysis of the urinary exosomal DNA |
5R01CA231465-05 |
|
|
Mckeon, Frank D. |
University Of Houston
United States |
Clonal Reconstruction and Targeting of the Correa Sequence |
5R01CA241600-05 |
|
|
Faris, Gregory W |
Numentus Technologies Inc.
United States |
Decoding Individual Exosomes in Cancer |
5R21CA236686-02 |
|
|
Bea, Jennifer Wright |
University Of Arizona
United States |
Adipose and Lean Soft Tissue Depots, Cancer Risk and Mortality in Postmenopausal Women |
3R01CA253302-03S1 |
|
Edward Sauter, M.D., Ph.D. |
Yennu, Sriram |
University Of Tx Md Anderson Can Ctr
United States |
Opioid-Sparing Interdisciplinary Interventions Addressing Pain in Head and Neck Cancer Patients |
5R21CA252446-02 |
|
Rachel Altshuler, Ph.D. |
Tamrazi, Benita |
Children'S Hospital Of Los Angeles
United States |
Brain iron accumulation as an in vivo quantifiable biomarker of neurocognitive dysfunction in pediatric brain tumor survivors |
5R21CA262978-02 |
|
Rachel Altshuler, Ph.D. |
Xing, Chengguo |
University Of Florida
United States |
Quantifying NNK metabolites to facilitate Kava lung cancer prevention clinical translation |
5R03CA273467-02 |
|
|
Moyer, Matthew T. |
Pennsylvania State Univ Hershey Med Ctr
United States |
CHARM 2: Chemotherapy for ablation and resolution of mucinous pancreatic cysts: a prospective, randomized, double-blind, multi-center clinical trial |
5R01CA222648-05 |
|
Asad Umar, D.V.M., Ph.D. |
Mustian, Karen M. |
University Of Rochester
United States |
Sexual Orientation and Gender Identity Data Collection in Community Oncology Practice |
3UG1CA189961-10S1 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
Rohan, Thomas E |
Albert Einstein College Of Medicine
United States |
Molecular markers of risk of subsequent invasive breast cancer in women wth ductal carcinoma in situ |
5R01CA218429-06 |
|
Christos Patriotis, Ph.D., M.Sc. |
Visovsky, Constance G. |
University Of South Florida
United States |
Home-Based Physical Activity Intervention for Taxane-Induced CIPN |
5R01CA229681-05 |
|
Goli Samimi, Ph.D., M.P.H. |
Hall, Adam Roger |
Wake Forest University Health Sciences
United States |
Detecting diverse nucleic acid biomarkers of cancer with solid-state nanopores |
1R33CA246448-01A1 |
RFA-CA-19-020 (R33 Clinical Trials Not Allowed) |
Guillermo Marquez, Ph.D. |
Agsalda-Garcia, Melissa Anne |
University Of Hawaii At Manoa
United States |
Raman-enhanced spectroscopy (RESpect) for anal dysplasia in HIV-positive patients |
1R21CA244078-01 |
PAR-18-020 (R21 Clinical Trial Optional) |
Guillermo Marquez, Ph.D. |
Kim, Kyungmann |
University Of Wisconsin-Madison
United States |
CP-CTNet Coordinating Center |
5U24CA242637-05 |
RFA-CA-18-030 (U24 Clinical Trials Required) |
Donald Johnsey |
Toriola, Adetunji T |
Washington University
United States |
Targeting RANK Pathway in Mammographic Density and Primary Breast Cancer Prevention |
5R37CA235602-05 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
Sen, Subrata |
University Of Tx Md Anderson Can Ctr
United States |
Circulating Biomarkers and Imaging for Early Detection of Pancreatic Cancer |
5U01CA214263-05 |
|
|
Ochoa, Augusto C. |
Lsu Health Sciences Center
United States |
Gulf South Minority/Underserved Clinical Trials Network (Gulf South M/U CTN) |
3UG1CA189854-10S1 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
Kulkarni, Swati |
Northwestern University At Chicago
United States |
Evaluating the protective effect of a tissue selective estrogen complex (TSEC) in women with newly diagnosed ductal carcinoma in situ |
5R01CA218436-05 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
Salvemini, Daniela |
Saint Louis University
United States |
A3AR agonists as a novel approach to mitigate chemotherapy induced neurotoxicity |
5R01CA230512-05 |
|
Rachel Altshuler, Ph.D. |
Singal, Amit |
Ut Southwestern Medical Center
United States |
Precision Risk Stratification and Screening for HCC among Patients with Cirrhosis in the United States |
5U01CA230694-05 |
|
|
Hecht, Stephen S |
University Of Minnesota
United States |
Clinical Trial of Watercress in Detoxification of Environmental Toxicants and Carcinogens |
5R01CA222005-05 |
|
Amit Kumar, Ph.D. |
Wu, Yun |
State University Of New York At Buffalo
United States |
Exosomal Thomsen-Friedenreich glycoantigen as a new biomarker for lung cancer screening and early detection |
5R21CA267934-02 |
PAR-20-292 (R21 Clinical Trial Optional) |
|
Tangen, Catherine M. |
Fred Hutchinson Cancer Center
United States |
PCPT and SELECT Cohorts: Core Infrastructure Support for Cancer Research |
5U01CA182883-11 |
|
Howard L. Parnes, M.D. |
King, Suzanne N |
University Of Louisville
United States |
Mechanisms underlying radiation-induced dysphagia |
5R21CA263107-02 |
PAR-20-292 (R21 Clinical Trial Optional) |
Nancy J. Emenaker, Ph.D., R.D.N., L.D., F.A.N.D. |
Ladas, Elena J. |
Columbia University Health Sciences
United States |
Probiotics for Prevention of Acute Graft-vs-Host Disease in Children with Cancer |
5R01CA201788-07 |
|
Gabriela Riscuta, M.D., C.N.S. |
Milbury, Kathrin |
University Of Tx Md Anderson Can Ctr
United States |
Dyadic yoga Program for Patients with Lung Cancer Undergoing Radiotherapy and their Family Caregivers |
5R37CA231522-06 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
Sirica, Alphonse E |
Federation Of Amer Soc For Exper Biology
United States |
The Cholangiocarcinoma Conference: Molecular Drivers, Microenvironment, and Precision Medicine |
1R13CA284494-01 |
|
Wendy Wang, Ph.D., M.Sc. |
Deng, Youping |
University Of Hawaii At Manoa
United States |
Circulating lipid and miRNA markers for early detection of breast cancer among women with abnormal mammograms |
5R01CA230514-05 |
|
|
Goel, Ajay |
Beckman Research Institute/City Of Hope
United States |
Exosomal Biomarkers for the Noninvasive Detection of Colorectal Cancer |
5R01CA227602-05 |
|
|
Rosenberg, Abby R |
Dana-Farber Cancer Inst
United States |
The Promoting Resilience in Stress Management (PRISM) Intervention: a multi-site randomized controlled trial for Adolescents and Young Adults with advanced cancer |
7R01CA222486-06 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
Grueber, Wesley B |
Columbia University Health Sciences
United States |
Neuron-macrophage interactions in models of chemotherapy-induced peripheral neuropathy |
5R21CA274588-02 |
|
Rachel Altshuler, Ph.D. |
You, Ming |
Methodist Hospital Research Institute
United States |
Transfer Application - R01 CA223804 - Chemoimmunoprevention of EGFR-Driven Non-Small Cell Lung Cancer |
5R01CA223804-05 |
|
|
Patel, Abhijit |
Yale University
United States |
Lung Cancer Screening via Ultrasensitive and Cost-efficient Analysis of Tumor DNA Signatures in Blood |
5U01CA233364-05 |
|
|
Carter, Bob S |
Massachusetts General Hospital
United States |
Liquid Biopsy for treatment stratification of IDH1.R132H and EGFRvIII mutant gliomas |
5U01CA230697-05 |
|
|
Cope, Timothy C |
Georgia Institute Of Technology
United States |
Novel Path to Chronic Sensorimotor Dysfunction and Treatment for Chemotherapy |
5R01CA221363-05 |
|
Rachel Altshuler, Ph.D. |
Agarwal, Ashutosh |
University Of Miami School Of Medicine
United States |
A comprehensive liquid biopsy platform for detection and prognostication in early stage breast cancer |
5U01CA233363-05 |
|
|
Lee, Hakho |
Massachusetts General Hospital
United States |
Early Detection through Novel OCEAN Technology - Ovarian Cancer Exosomal Analysis with Nanoplasmonics |
5U01CA233360-05 |
|
|
Wheeler, Stephanie Brooke |
Univ Of North Carolina Chapel Hill
United States |
Optimizing Endocrine Therapy Adherence through Motivational Interviewing and Text Interventions |
5R01CA237357-05 |
PA-18-004 (R01 Clinical Trial Optional) |
|
Largaespada, David Andrew |
University Of Minnesota
United States |
Recurrent Tumor-Specific Alternately Processed Transcripts as a Source of Neoantigens for NF1-associated Malignant Peripheral Nerve Sheath Tumor Immunoprevention |
5UH3CA244687-05 |
RFA-CA-19-012 |
|
Armstrong, Gregory |
St. Jude Children'S Research Hospital
United States |
Sen-Survivors: An open-label intervention trial for frailty and senescence |
1U01CA246510-01 |
|
Eileen Dimond, R.N., M.S. |
Allen, Peter J |
Duke University
United States |
Preventing an Incurable Disease: The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial) |
5R01CA235677-05 |
|
|
Rapaport, Mark Hyman |
University Of Utah
United States |
Massage for Prostate Cancer-Related Fatigue |
1R21CA263453-01 |
PAR-20-292 (R21 Clinical Trial Optional) |
Goli Samimi, Ph.D., M.P.H. |
Kleckner, Ian Robert |
University Of Maryland Baltimore
United States |
Effects of exercise during platinum chemotherapy on neuropathy: examining the interoceptive brain system and inflammation |
5R21CA259422-02 |
PAR-20-292 (R21 Clinical Trial Optional) |
|
Stabile, Laura P. |
University Of Pittsburgh At Pittsburgh
United States |
Super-Resolution Imaging of Higher-Order Heterochromatin Structure for Early Detection of Lung Carcinogenesis |
5R21CA259787-02 |
PAR-20-292 (R21 Clinical Trial Optional) |
|
Davis, Jennifer Sarah |
University Of Kansas Medical Center
United States |
Colorectal cancer risk factors, risk prediction and blood-based biomarker by tumor consensus molecular subtype |
7U01CA222163-04 |
|
Claire Zhu, Ph.D. |
Park, Kwon-Sik |
University Of Virginia
United States |
Targeting BCAT1 and branched-chain amino acid metabolism for the detection and prevention of SCLC |
5U01CA224293-05 |
|
Eva Szabo, M.D. |
Weaver, Alissa M |
Vanderbilt University
United States |
Phenotype Interactions in SCLC Development and Detection |
5U01CA224276-05 |
|
Eva Szabo, M.D. |
Yeh, Jennifer M. |
Boston Children'S Hospital
United States |
Genetic testing to guide pediatric cancer care and follow up: using anthracycline-associated cardiac toxicity as a model for the future |
5R01CA227576-05 |
|
Eileen Dimond, R.N., M.S. |
Beane, Jennifer Ellen |
Boston University Medical Campus
United States |
PRISTINE: Pre-cancer histology identification of Endobronchial biopsies using deep learning |
1R21CA253498-01 |
|
Guillermo Marquez, Ph.D. |
Ghosh, Moumita |
University Of Colorado Denver
United States |
(PQ1) Progenitor cell malfunction, mutations and changes in microenvironment: A dynamic risk spectrum for cancer evolution |
5R01CA219893-06 |
|
Eva Szabo, M.D. |
Lin, Po-Ju |
University Of Rochester
United States |
Assessing the role of the interoceptive brain system in the pathophysiology and treatment of chemotherapy-induced peripheral neuropathy |
1R21CA256154-01A1 |
PAR-20-292 (R21 Clinical Trial Optional) |
Marge Good, R.N., M.P.H., O.C.N. |
Hoffman, Amy Jude |
University Of Nebraska Medical Center
United States |
Managing Fatigue Using Virtual Reality for Post-Operative Lung Cancer Patients |
5R01CA205025-06 |
|
|
Dryden-Peterson, Scott Lee |
Brigham And Women'S Hospital
United States |
A multilevel intervention (Potlako+) to improve timely cancer detection and treatment initiation |
5R01CA236546-05 |
|
|
Ogilvie, Gina |
University Of British Columbia
United States |
Addressing emerging health system priorities in cervical cancer prevention: determining optimal strategies for human papillomavirus test-based screening and triage |
5R01CA221918-05 |
|
Claire Zhu, Ph.D. |
Altorki, Nasser Khaled |
Weill Medical Coll Of Cornell Univ
United States |
Intercepting progression from pre-invasive to invasive lung adenocarcinoma |
3UH3CA244697-05S1 |
|
|
Perelman, Lev T |
Beth Israel Deaconess Medical Center
United States |
Spectro-Holographic Instrument for Dynamic Sensing of Cancer Progression |
5R01CA228029-06 |
|
|
Lin, Daniel W. |
Fred Hutchinson Cancer Center
United States |
Prostate cancer Active Surveillance Study (PASS) Cohort: Infrastructure Support for Cancer Research |
5U01CA224255-06 |
|
|
Kassie, Fekadu |
University Of Minnesota
United States |
Lung cancer prevention and treatment by targeting ALDH1 and CD44 expressing putative lung cancer stem cells |
5R01CA231210-05 |
|
|
Krasnow, Mark A |
Stanford University
United States |
Molecular mechanisms of SCLC initiation and detection in mice and humans |
5U01CA231851-05 |
|
Eva Szabo, M.D. |
Lok, Anna S.F. |
University Of Michigan At Ann Arbor
United States |
NOVEL STRATEGIES TO IMPROVE LIVER CANCER SURVEILLANCE UPTAKE AND EARLY DETECTION |
5U01CA230669-05 |
|
|
Lipkin, Steven M |
Weill Medical Coll Of Cornell Univ
United States |
(PQ1) Adaptive immune and microbial mechanisms regulating Lynch syndrome penetrance |
5R01CA231283-05 |
|
Asad Umar, D.V.M., Ph.D. |
Chung, Fung-Lung |
Georgetown University
United States |
gamma-OHPdG as a prognostic biomarker of HCC recurrence and its prevention |
5U01CA220477-05 |
|
Wendy Wang, Ph.D., M.Sc. |
Mehta, Anand S |
Medical University Of South Carolina
United States |
Translation of a biomarker panel for the early detection of hepatocellular carcinoma |
5R01CA237659-05 |
|
|
Perlis, Michael Lloyd |
University Of Pennsylvania
United States |
The Association Between CBT-I Dose, Sleep Duration, and Fatigue in Breast Cancer Patients |
1R21CA270987-01 |
PAR-20-292 (R21 Clinical Trial Optional) |
Marge Good, R.N., M.P.H., O.C.N. |
Lipkin, Steven M |
Weill Medical Coll Of Cornell Univ
United States |
Neoantigen Vaccination for Lynch Syndrome Immunoprevention |
5U01CA233056-05 |
|
Mark Steven Miller, Ph.D. |
Phillips, Nicholas S |
St. Jude Children'S Research Hospital
United States |
Culturally adapted mobile treatment of chronic pain in adolescent survivors of pediatric bone sarcoma |
1R61CA280978-01 |
|
|
Mishra, Lopa |
Feinstein Institute For Medical Research
United States |
Pathway Specific Functional Biomarkers for the Early Detection of Liver Cancer |
7U01CA230690-06 |
|
|
Meltzer, Stephen J |
Johns Hopkins University
United States |
Facile screening for esophageal cancer in LMICs |
5UH3CA211457-05 |
|
Matthew Young, Ph.D. |
Dasgupta, Piyali |
Marshall University
United States |
Capsaicin and small cell lung cancer therapy |
2R15CA161491-03 |
|
Gabriela Riscuta, M.D., C.N.S. |
Reese, Jennifer Barsky |
Research Inst Of Fox Chase Can Ctr
United States |
Addressing Sexual Concerns in Breast Cancer Survivors: RCT of a Novel Couple-Based Intervention |
5R01CA222124-05 |
|
Ellen Richmond, M.S., G.N.P.-B.C. |
Curiel-Lewandrowski, Clara |
University Of Arizona
United States |
Targeted Prevention for Non-Melanoma Skin Cancer |
5P01CA229112-05 |
PAR-18-290 (P01 Clinical Trial Optional) |
|
Anderson, Karen S. |
Arizona State University-Tempe Campus
United States |
Rapid Point of Care Detection of HPV-Associated Malignancies |
5UH3CA211415-06 |
|
Christos Patriotis, Ph.D., M.Sc. |
Bylund, Carma L. |
University Of Florida
United States |
Dignity Therapy for Older Cancer Patients: Identifying Mechanisms and Moderators |
5R01CA253330-03 |
|
|
Deng, Youping |
University Of Hawaii At Manoa
United States |
Profiling genome-wide circulating ncRNAs for the early detection of lung cancer |
5R01CA223490-05 |
|
|
Demehri, Shadmehr |
Massachusetts General Hospital
United States |
Epithelium-derived alarmins role in breast cancer immunoprevention |
5U01CA233097-05 |
|
Mark Steven Miller, Ph.D. |
Nyante, Sarah Jane |
Univ Of North Carolina Chapel Hill
United States |
Understanding the biological basis for the association between parenchymal texture features and breast cancer risk |
5R01CA237129-05 |
|
|
Cole, Peter D |
Rutgers Biomedical And Health Sciences
United States |
Identifying children with subclinical neurocognitive decline and susceptibility to oxidative damage during the early months of therapy for ALL |
7R01CA220568-05 |
|
|
Ragin, Camille C |
Research Inst Of Fox Chase Can Ctr
United States |
Community to Molecular Approaches in Early Screening and Diagnosis to Promote Equitable Outcomes Through the Continuum of Care in Cancer Among Populations of African Ancestry |
1R13CA284826-01 |
|
|
Coleman, William B |
American Society/Investigative Pathology
United States |
2023 Annual Meeting of the American Society for Investigative Pathology |
1R13CA284830-01 |
|
|
Hoshida, Yujin |
Ut Southwestern Medical Center
United States |
Reverse-engineering precision liver cancer chemoprevention |
3R01CA233794-05S1 |
|
|
Spira, Avrum E |
Boston University Medical Campus
United States |
The Lung PCA: A Multi-Dimensional Atlas of Pulmonary Premalignancy |
1U2CCA233238-01 |
|
Richard Mazurchuk, Ph.D. |
Coffey, Robert J. |
Vanderbilt University Medical Center
United States |
Integrative Single-Cell Atlas of Host and Microenvironment in Colorectal Neoplastic Transformation |
3U2CCA233291-01S2 |
|
Richard Mazurchuk, Ph.D. |
Snyder, Michael P. |
Stanford University
United States |
Precancer Atlas of Familial Adenomatous Polyposis |
3U2CCA233311-01S1 |
|
Richard Mazurchuk, Ph.D. |
Hwang, Eun-Sil Shelley |
Duke University
United States |
Breast Pre-Cancer Atlas Center |
3U2CCA233254-01S3 |
|
Richard Mazurchuk, Ph.D. |
Sorger, Peter Karl |
Harvard Medical School
United States |
Pre-cancer atlases of cutaneous and hematologic origin (PATCH Center) |
3U2CCA233262-01S2 |
|
Sudhir Srivastava, Ph.D., M.P.H. |
Penedo, Frank J |
University Of Miami Coral Gables
United States |
eHealth Supported Mindfulness-based Music Therapy Intervention (eMBMT) in Hemopoietic Stem Cell Transplant Patients |
5R61CA263335-02 |
|
|
Umbricht, Christopher B |
Johns Hopkins University
United States |
Discovery and validation of early molecular breast cancer risk markers in benign breast disease |
5R01CA222779-06 |
|
|
Shen, Chan |
Pennsylvania State Univ Hershey Med Ctr
United States |
The effects of hydrocodone rescheduling on pain management of older lung cancer patients |
1R21CA277849-01 |
|
Rachel Altshuler, Ph.D. |
Tighiouart, Mourad |
Cedars-Sinai Medical Center
United States |
Advancing Analysis and Interpretation of Adverse Events and PROs in Cancer Clinical Trials |
3U01CA232859-05S1 |
|
Rachel Altshuler, Ph.D. |
Mohile, Supriya G |
University Of Rochester
United States |
Understanding Treatment Tolerability in Older Patients with Cancer |
3U01CA233167-05S1 |
|
Rachel Altshuler, Ph.D. |
Basch, Ethan M. |
Univ Of North Carolina Chapel Hill
United States |
Analyzing and Interpreting PRO-CTCAE with CTCAE and Other Clinical Data to Characterize Drug Tolerability |
3U01CA233046-05S1 |
|
Rachel Altshuler, Ph.D. |
Gray, Robert J |
Dana-Farber Cancer Inst
United States |
Analysis of ECOG-ACRIN adverse event data to optimize strategies for the longitudinal assessment of tolerability in the context of evolving cancer treatment paradigms (EVOLV) |
3U01CA233169-05S1 |
|
Rachel Altshuler, Ph.D. |
You, Ming |
Methodist Hospital Research Institute
United States |
Chemoprevention of lung cancer by targeting lonidamine to mitochondria |
5R01CA232433-05 |
|
|
Levine, Jon David |
University Of California, San Francisco
United States |
Chronic Chemotherapy Peripheral Neuropathy: Role of Neuroplasticity and Stress |
5R01CA250017-05 |
|
Rachel Altshuler, Ph.D. |
Nechiporuk, Alex |
Oregon Health & Science University
United States |
High-throughput identification of molecular targets responsible for drug-induced peripheral neuropathies. |
1R21CA260025-01A1 |
|
Rachel Altshuler, Ph.D. |
Melemedjian, Ohannes Kevork |
University Of Maryland Baltimore
United States |
Identification of novel targets for the treatment of chemotherapy-induced painful peripheral neuropathy |
1R01CA249939-01 |
|
Rachel Altshuler, Ph.D. |
Duncavage, Eric J |
Washington University
United States |
Whole Genome Sequencing for Genomic Evaluation and Risk Stratification of Patients with Myelodysplastic Syndromes |
1UH2CA272904-01 |
|
|
Enzinger, Andrea C |
Dana-Farber Cancer Inst
United States |
Development of A Mindfulness-Based Mobile Health Intervention for Patients Coping with Pain from Advanced Malignancies |
5R21CA270069-02 |
|
|
Hirsch, Fred R |
Icahn School Of Medicine At Mount Sinai
United States |
Vulnerability of SARS- CoV-2 Infection in Lung Cancer Based on Serological Antibody Analyses |
3U54CA260560-02S2 |
|
|
Peters, Jeffrey M |
Pennsylvania State University, The
United States |
Unique targeting of PPARβ/δ regulation for cancer prevention and therapy |
5R01CA239256-05 |
|
|
Katona, Bryson William |
University Of Pennsylvania
United States |
Defining the phenotype and cancer penetrance of CTNNA1 loss-of-function germline variants |
5R21CA267949-02 |
PAR-20-292 (R21 Clinical Trial Optional) |
|
Yennu, Sriram |
University Of Tx Md Anderson Can Ctr
United States |
A Combination Therapy to Treat Cancer-Related Fatigue |
5R01CA231521-05 |
|
|
Crew, Katherine D |
Columbia University Health Sciences
United States |
Multicenter trial of decision support for breast cancer chemoprevention |
3R01CA226060-05S1 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
You, Ming |
Methodist Hospital Research Institute
United States |
Inhibition of Oral Tumorigenesis by Antitumor B |
7R01CA205633-06 |
|
Eva Szabo, M.D. |
Sedrak, Mina S |
University Of California Los Angeles
United States |
Using Senolytics to Improve Physical Function in Older Breast Cancer Survivors |
5R21CA277660-03 |
|
|
Houghton, A Mcgarry |
Fred Hutchinson Cancer Center
United States |
Tumor-specific autoantibodies for SCLC early detection |
5R01CA243328-06 |
|
|
Figueiredo, Jane C. |
Cedars-Sinai Medical Center
United States |
Diversity and Determinants of the Immune-Inflammatory Response to SARS-CoV-2 |
3U54CA260591-02S3 |
|
|
Rodriguez, Gustavo |
Northshore University Healthsystem
United States |
Vitamin D and Progestins for the Chemoprevention of Fallopian Tube/Ovarian Cancer |
3R01CA214606-05S1 |
|
Marjorie Perloff, M.D. |
Badu-Tawiah, Abraham |
Ohio State University
United States |
Multiplexed Paper-Based Blood Test for Early-Stage Colorectal Cancer Screening |
5R21CA270727-02 |
PAR-20-292 (R21 Clinical Trial Optional) |
|
Marchetti, Dario |
University Of New Mexico Health Scis Ctr
United States |
Mechanisms of melanoma brain metastasis by CTCs isolated from patients' blood and CSF |
5R01CA216991-07 |
|
|
Noble, Mark D |
University Of Rochester
United States |
Prevention and treatment of paclitaxel-induced peripheral neuropathy |
5R21CA277447-02 |
|
Rachel Altshuler, Ph.D. |
Morilak, David A |
University Of Texas Hlth Science Center
United States |
Cognitive impairment associated with androgen deprivation therapy for prostate cancer |
5R01CA224672-05 |
|
|
Fan, Rong |
Yale University
United States |
Immuno-Serological Assays for Monitoring COVID19 in Patients with Hematologic Malignancies |
3U01CA260507-02S2 |
|
|
Mantis, Nicholas J. |
Wadsworth Center
United States |
High-Throughput Dried Blood Spot (HT-DBS) Technologies in SARS COV-2 Serology and Vaccinology |
3U01CA260508-02S1 |
|
|
Darie, Costel C. |
Clarkson University
United States |
PA-21-071 for Pathea Bruno to CA260126-01 Identifying a proteomic signature for breast cancer detection in breast milk and serum |
3R15CA260126-01A1S1 |
|
|
Kahalley, Lisa Schum |
Baylor College Of Medicine
United States |
White Matter Toxicity and Neurocognitive Outcomes in Pediatric Brain Tumor Patients Treated with Proton Beam Radiation Therapy |
5R01CA221197-05 |
|
|
Smalley, Keiran |
H. Lee Moffitt Cancer Ctr & Res Inst
United States |
Defining and targeting the epigenetic programs involved in melanoma development |
5R21CA267141-02 |
PAR-20-292 (R21 Clinical Trial Optional) |
Winfred Malone, Ph.D., M.P.H. |
Cao, Lei |
Ohio State University
United States |
Cancer prevention and treatment by activation of a brain-adipocyte axis |
5R01CA166590-10 |
|
Winfred Malone, Ph.D., M.P.H. |
Shu, Xiao-Ou |
Vanderbilt University Medical Center
United States |
Use of Circulating MicroRNAs for Early Detection and Risk Assessment for Pancreatic Cancer |
5R01CA227133-05 |
|
Matthew Young, Ph.D. |
Yu, Anthony Francis |
Sloan-Kettering Inst Can Research
United States |
Effects of Exercise on Changes in Cardiovascular Biomarkers in Patients with Breast Cancer During Anthracycline-based Chemotherapy |
5R03CA277194-02 |
|
Eileen Dimond, R.N., M.S. |
Zeng, Melody Yue |
Weill Medical Coll Of Cornell Univ
United States |
Dissecting the interplay between immunoglobulin G and the gut microbiome in cancer progression and metastasis |
5R21CA270998-02 |
|
|
Singal, Amit |
Ut Southwestern Medical Center
United States |
Precision Screening for Hepatocellular Carcinoma in Patients with Cirrhosis |
5R01CA222900-06 |
|
|
Nathan, Cherie-Ann O |
Louisiana State Univ Hsc Shreveport
United States |
Targeting Fibroblast Growth Factor Receptor-2b in prevention and treatment of cutaneous Squamous cell carcinoma. |
5R01CA217180-05 |
|
Howard L. Parnes, M.D. |
Germain, Doris A |
Icahn School Of Medicine At Mount Sinai
United States |
Exploring ovarian-derived hormone STC1 as the mediator of the protective effect of breast feeding against breast cancer. |
5R21CA270702-02 |
PAR-20-292 (R21 Clinical Trial Optional) |
|
Hofseth, Lorne J |
University Of South Carolina At Columbia
United States |
Harnessing the power of p53 with Panaxynol from American Ginseng to suppress colitis and prevent colon cancer |
3R01CA246809-05S1 |
|
|
Degnim, Amy C |
Mayo Clinic Rochester
United States |
Biomarkers to Improve Targeting of Breast Cancer Prevention in Women with Atypical Hyperplasia |
5R01CA237607-05 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
Singh, Shivendra |
University Of Pittsburgh At Pittsburgh
United States |
Biomarkers of Sulforaphane/Broccoli Sprout Extract in Prostate Cancer |
5R01CA225716-05 |
|
Howard L. Parnes, M.D. |
Thomas, Christoforos |
Methodist Hospital Research Institute
United States |
Exploring the role of ER Beta in disease penetrance in individuals with Li-Fraumeni syndrome |
5R21CA267386-03 |
PAR-20-292 (R21 Clinical Trial Optional) |
Winfred Malone, Ph.D., M.P.H. |
Pandharipande, Pari Vijay |
Ohio State University
United States |
Precision Management of Cystic Precursors to Pancreatic Cancer |
5R01CA237133-06 |
|
Matthew Young, Ph.D. |
Smith, Ellen Mary Lavoie |
University Of Alabama At Birmingham
United States |
Duloxetine to Prevent Oxaliplatin-Induced Chemotherapy-Induced Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase II to Phase III Study |
5R01CA235726-07 |
|
|
Hayes, Richard Bernard |
New York University School Of Medicine
United States |
The Oral Microbiome and Upper Aerodigestive Squamous Cell Cancer |
5R01CA159036-09 |
|
|
Somers, Tamara J |
Duke University
United States |
A Mobile Health Behavioral Pain Intervention Protocol for Breast Cancer Patients with Pain in Medically Underserved Communities: A Randomized Controlled Trial |
5R01CA237892-05 |
|
|
Porter, Laura S |
Duke University
United States |
Couple Communication Skills Training for Advanced Cancer |
5R01CA229425-05 |
|
|
Russell, John A |
University Of Wisconsin-Madison
United States |
Treatment of Functional Deficits IN tongue muscles induced by radiation and chemoradiation treatment |
5R37CA225608-07 |
|
|
Varmus, Harold E. |
Weill Medical Coll Of Cornell Univ
United States |
Studies of the initiation and progression of small cell lung cancer using cells derived by differentiation from human pluripotent stem cells |
5U01CA224326-05 |
|
Eva Szabo, M.D. |
Yaddanapudi, Kavitha |
University Of Louisville
United States |
A Stem Cell Based Exosomal Vaccine for the Prevention of Cancer |
5R21CA277314-02 |
PAR-20-292 (R21 Clinical Trial Optional) |
|
Temprosa, Marinella |
George Washington University
United States |
22/22 Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) – Biostatistics Center |
2U01DK048489-28 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
Digiovanni, John |
University Of Texas At Austin
United States |
Identification of Natural Compound Combinations for Prevention of Prostate Cancer |
5R01CA228404-05 |
|
Marjorie Perloff, M.D. |
Feliciano, Elizabeth Marjorie Cespedes |
Kaiser Foundation Research Institute
United States |
D3-creatine dilution to determine skeletal muscle mass in colon cancer patients |
5R01CA240394-04 |
PAR-18-893 (R01 Clinical Trial Optional) |
Gabriela Riscuta, M.D., C.N.S. |
Khan, Seema Ahsan |
Northwestern University At Chicago
United States |
Determinants of transdermal drug delivery to the normal and the radiated breast |
5R01CA235647-05 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
Sorror, Mohamed |
Fred Hutchinson Cancer Center
United States |
Novel Intervention Approaches to Alleviate Allogeneic Transplant-Related Morbidity and Mortality |
5R01CA227092-06 |
|
|
El-Bayoumy, Karam E |
Pennsylvania State Univ Hershey Med Ctr
United States |
Chemoprevention by Black Raspberry of Oral Cancer Induced by Tobacco Carcinogens: Translational Studies |
5R01CA173465-10 |
|
|
Herrmann, Joerg |
Mayo Clinic Rochester
United States |
TrAstuzumab Cardiomyopathy Therapeutic Intervention with Carvedilol (TACTIC) Trial |
5R01CA233610-06 |
PA-18-003 (R01 Clinical Trial Optional) |
Eileen Dimond, R.N., M.S. |
Mehta, Anand S |
Medical University Of South Carolina
United States |
Glycopathology of HCC: identification of the source cells of serum fucosylation |
5U01CA226052-05 |
PAR-17-206 (U01) |
|
Drake, Richard R. |
Medical University Of South Carolina
United States |
Targeted Isolation and Identification of Sialylated Glycoproteins in Cancer Tissues, Cells and Biofluids |
5R33CA267226-03 |
RFA-CA-21-004 (R33 Clinical Trial Not Allowed) |
|
Hunter, Jessica Ezzell |
Kaiser Foundation Research Institute
United States |
Leveraging tumor registries and pathology specimens to facilitate genetic testing and traceback for ovarian cancer |
5U01CA244323-04 |
|
|
Sowers, Lawrence C |
University Of Texas Med Br Galveston
United States |
Cytosine Deamination Adducts and Cancer Etiology |
5R01CA228085-05 |
|
|
Bae-Jump, Victoria Lin |
Univ Of North Carolina Chapel Hill
United States |
Obesity-driven Metabolic and Molecular Biomarkers of Metformin Response in Endometrial Cancer |
5R37CA226969-07 |
|
|
Dashwood, Roderick H |
Texas A&M University Health Science Ctr
United States |
CCAR2 as a Target for Prevention of Colorectal Cancer. |
5R01CA122959-11 |
|
|
Esserman, Laura J |
University Of California, San Francisco
United States |
Extending the Diversity, Reach, and Generalizability of the WISDOM Study |
5R01CA237533-05 |
|
|
Furuta, Saori |
Case Western Reserve University
United States |
Normalizing arginine metabolism with sepiaptein for immunostimulatory-shift ofHER2+ breast cancer |
5R01CA248304-05 |
|
|
Zhang, Fan |
University Of Florida
United States |
R21 MPI microRNA directed therapy for treating early stage pancreatic cancer |
5R21CA277263-02 |
|
|
Thompson, Patricia Ann |
State University New York Stony Brook
United States |
Three-Arm randomized trial comparing the effect of aspirin, sulindac or no treatment control on breast density in patients with elevated breast cancer risk |
5R01CA235720-05 |
|
|
Nath, Kavindra |
University Of Pennsylvania
United States |
Metabolic Biomarkers of Response of Mantle Cell Lymphoma to Bruton Tyrosine Kinase Inhibition |
5R01CA228457-05 |
|
|
Kinney, Anita Y. |
American Society Of Preventive Oncology, Inc.
United States |
2024 Annual Conference Grant: American Society of Preventive Oncology |
1R13CA290995-01 |
|
Wendy Wang, Ph.D., M.Sc. |
Robertson, Gavin P. |
Pennsylvania State Univ Hershey Med Ctr
United States |
Targeting Aldehyde Dehydrogenase for Cancer Prevention |
5R01CA241148-05 |
|
|
Nappi, Lucia |
Provincial Health Services Authority
United States |
Integrating investigational miR371a-3p with conventional radiology imaging for earlier and more precise detection of active germ cell malignancy: A BCC/SWOG/S1823 secondary use of data collaboration. |
5R37CA264798-02 |
PAR-19-264 (R01 Clinical Trial Optional) |
|
Mallick, Parag Kumar |
Stanford University
United States |
Pathomic Predictors of Prostate Cancer Progression |
5R01CA249899-05 |
PAR-19-264 (R01 Clinical Trial Optional) |
|
Vigneron, Daniel B |
University Of California, San Francisco
United States |
Hyperpolarized C-13 MRI for Early Detection of Aggressive Prostate Cancer in Active Surveillance Patients |
5U01CA232320-05 |
PAR-16-089 (U01) |
|
Kisiel, John |
Mayo Clinic Rochester
United States |
Multi-site Gastrointestinal Cancer Detection by Stool DNA Methylation |
5R37CA214679-07 |
|
|
Haab, Brian B. |
Van Andel Research Institute
United States |
Subpopulations of Pancreatic Cancer Cells Defined by Glycan Markers |
5U01CA226158-05 |
PAR-17-206 (U01) |
|
Shen, Qiang |
Lsu Health Sciences Center
United States |
Chemoprevention of Breast Cancer by Targeting Glucose Metabolism with HJC0152 |
5R01CA226001-06 |
|
|
Singh, Shivendra |
University Of Pittsburgh At Pittsburgh
United States |
The Role of FoxQ1 in Breast Cancer Chemoprevention by Allium Constituents - R01CA219180 |
5R01CA219180-05 |
|
|
Li, Hongjin |
University Of Illinois At Chicago
United States |
A Multi-Omics Study of the Effect and Mechanisms of Acupuncture on Psychoneurological Symptoms Among Breast Cancer Survivors |
5R21CA277153-02 |
|
|
Nelson, Randy J. |
West Virginia University
United States |
Mechanism Underlying Sleep Disruption by Mammary Tumors |
5R21CA276027-02 |
|
|
Chen, Grace Y. |
University Of Michigan At Ann Arbor
United States |
Targeting cancer stem-like cells and inflammation for colon cancer chemoprevention |
5R21CA273646-02 |
|
|
Shelby, Rebecca A |
Duke University
United States |
Persistent Post-Mastectomy Pain: Randomized Clinical Trial of Targeted Pain Coping Skills Training (Targeted-PCST) with Mediational Analysis |
5R01CA249959-05 |
|
|
Dandoy, Christopher Eugene |
Cincinnati Childrens Hosp Med Ctr
United States |
The 11th Annual PTCTC Educational Meeting, The First 100 Days After Stem Cell Transplant |
1R13HL173950-01 |
|
|
Coleman, William B |
American Society/Investigative Pathology
United States |
2024 Annual Meeting of the American Society for Investigative Pathology |
1R13CA290991-01 |
|
|
Schedin, Pepper J |
Oregon Health & Science University
United States |
NSAIDs During Postpartum Involution for Breast Cancer Chemoprevention |
5R01CA169175-11 |
|
|
Eibl, Guido Erwin Michael |
University Of California Los Angeles
United States |
Chemoprevention and mechanisms of obesity-promoted pancreatic adenocarcinoma |
5P01CA236585-04 |
PAR-18-290 (P01 Clinical Trial Optional) |
|
Hansen, Laura A |
Creighton University
United States |
Targeting aberrant anti-apoptotic signaling for prevention of skin cancer |
5R01CA253573-04 |
|
Howard L. Parnes, M.D. |
Bride, Colleen M Mc |
Emory University
United States |
Testing a Low Cost Population- and Theory-Based Outreach Intervention to Engage Ovarian Cancer Survivors and their Close Relatives to Consider Genetic Services |
5U01CA240581-04 |
PAR-18-616 (U01 Clinical Trial Optional) |
|
Barroilhet, Lisa M |
University Of Wisconsin-Madison
United States |
Repurposing Atovaquone for Preventing Ovarian Cancer: An Example of Successful Inhibition of Oxidative Phosphorylation |
3R01CA238423-04S1 |
|
|
Rozengurt, Juan Enrique |
University Of California Los Angeles
United States |
Interaction between Chronic Stress and Obesity in Pancreatic Cancer Progression |
5R21CA258125-02 |
|
|
Frazier, A Lindsay |
Dana-Farber Cancer Inst
United States |
Assay Validation of a Circulating miRNA Test for Diagnosis and Monitoring of Malignant Germ Cell Tumors |
5UH3CA240688-04 |
|
|
Kelleher, Sarah |
Duke University
United States |
Initial Testing of a Mobile App Pain Coping Intervention for Outpatient Oncology Settings |
1R21CA273832-01A1 |
|
|
Pitteri, Sharon |
Stanford University
United States |
Glycosylation and Immune Evasion in Urologic Tumors |
5U01CA226051-05 |
|
|
Richards-Kortum, Rebecca R. |
Rice University
United States |
Low-cost mobile colposcopy and confocal imaging for global prevention of cervical cancer |
5R01CA251911-04 |
|
|
Sehgal, Ashwini |
Case Western Reserve University
United States |
Pain and Immobility After Breast Cancer Surgery: A Community-Based Randomized Controlled Trial of Myofascial Massage Treatment |
5R01CA229287-04 |
|
Goli Samimi, Ph.D., M.P.H. |
Grace, Peter M |
University Of Tx Md Anderson Can Ctr
United States |
PQ12 Targeting HDAC6 for Chemotherapy-Induced Neuropathy and Chemobrain |
5R01CA227064-06 |
|
|
Azizoddin, Desiree R |
University Of Oklahoma Hlth Sciences Ctr
United States |
Leveraging mHealth to deliver integrated pain-CBT, opioid monitoring, and self-management support for advanced cancer patients coping with chronic pain |
5R21CA263838-02 |
|
|
Borges, Chad R |
Arizona State University-Tempe Campus
United States |
Plate reader assays to forensically assess exposure of plasma and serum to thawed conditions |
5R21CA269091-02 |
RFA-CA-21-005 (R21 Clinical Trial Not Allowed) |
|
Schloss, Patrick David |
University Of Michigan At Ann Arbor
United States |
muMS2: an open source R package for analyzing and integrating multi-omics datasets to improve early detection and understanding of colorectal cancer |
5U01CA264071-02 |
RFA-CA-21-014 (U01 Clinical Trial Optional) |
|
Chapkin, Robert Stephen |
Texas A&M Agrilife Research
United States |
Targeting plasma membrane spatial dynamics to suppress aberrant Wnt signaling |
5R01CA244359-04 |
|
|
Phd, Ralph Weissleder, Md, |
Massachusetts General Hospital
United States |
Ultrasenstive vesicle analysis in precancerous pancreatic neoplasm (IPMN) |
5R01CA237332-04 |
PAR-16-276 (R01) |
|
Kumar, Nagi B. |
H. Lee Moffitt Cancer Ctr & Res Inst
United States |
Phase II Clinical trial of GTC in Men on Active Surveillance |
5R01CA235032-05 |
|
Howard L. Parnes, M.D. |
Radisky, Derek C |
Mayo Clinic Jacksonville
United States |
Involution-based biomarkers of breast cancer risk |
3R01CA237602-04S1 |
|
|
Lokshin, Anna E |
University Of Pittsburgh At Pittsburgh
United States |
Development of Novel Ovarian Cancer Biomarkers for Early Detection Algorithms |
5R01CA247220-04 |
|
|
Hruska, Carrie B |
Mayo Clinic Rochester
United States |
Density MATTERS Clinical Trial |
5R01CA239200-04 |
|
|
Rogers, Laura Q |
University Of Alabama At Birmingham
United States |
Role of gut microbe composition in psychosocial symptom response to exercise training in breast cancer survivors |
5R01CA235598-05 |
|
Gabriela Riscuta, M.D., C.N.S. |
Oskeritzian, Carole A |
University Of South Carolina At Columbia
United States |
Novel modalities for prostate cancer screening: mast cells as predictors of disease, disease aggressiveness and marks of disease disparity |
1R21CA274021-01A1 |
|
Guillermo Marquez, Ph.D. |
Chibwesha, Carla J |
Univ Of North Carolina Chapel Hill
United States |
Acceptability and feasibility of combination treatment for cervical precancer among South Africa women living with HIV |
5R01CA250850-04 |
|
|
Taouli, Bachir |
Icahn School Of Medicine At Mount Sinai
United States |
Abbreviated MRI for HCC screening in cirrhotic patients |
5R01CA249765-04 |
|
|
Thakur, Mathew Laxman |
Thomas Jefferson University
United States |
Noninvasive, Uniplex, Molecular, Pathomic Urinary Assay for Detection of Prostate Cancer |
5R01CA249921-04 |
|
|
Johnson, Constance Margaret |
University Of Texas Hlth Sci Ctr Houston
United States |
The relationship between fMRI and patient-reported outcomes in chemotherapy-induced neuropathy: A diversity supplement |
3R01CA245054-04S1 |
|
Rachel Altshuler, Ph.D. |
Simone, Donald |
University Of Minnesota
United States |
Neural Mechanisms of Cancer Pain |
5R01CA241627-05 |
|
Rachel Altshuler, Ph.D. |
Mao, Jun J |
Sloan-Kettering Inst Can Research
United States |
Effect and Mechanism of Acupuncture for Cancer-related Cognitive Impairment (ENHANCE) |
5R01CA240417-04 |
|
|
Iyer, Prasad G. |
Mayo Clinic Rochester
United States |
Minimally Invasive Molecular Approaches for the Detection of Barrett’s Esophagus and Esophageal Adenocarcinoma |
5R01CA241164-05 |
|
|
Svatek, Robert Scott |
University Of Texas Hlth Science Center
United States |
eRapa for bladder cancer prevention |
5R01CA252057-04 |
PAR-19-183 (R01 Clinical Trial Optional) |
Howard L. Parnes, M.D. |
Sant, Shilpa |
University Of Illinois At Chicago
United States |
Three-dimensional organoid models to study breast cancer progression |
4R37CA232209-06 |
|
|
Hartman, Terryl J. |
Emory University
United States |
Fiber-rich Foods to Treat Obesity and Prevent Colon Cancer |
5R01CA245063-04 |
|
|
Goggins, Michael G. |
Johns Hopkins University
United States |
Using Markers to Improve Pancreatic Cancer Screening |
5R01CA176828-09 |
|
|
Linnes, Jacqueline |
Purdue University
United States |
Point-of-care screening test for early cervical cancer detection |
5R01CA246315-04 |
|
|
Brenner, Dean E. |
University Of Michigan At Ann Arbor
United States |
Early Phase Clinical Cancer Prevention Consortium |
5UG1CA242632-04 |
RFA-CA-19-031 (UG1 Clinical Trial Required) |
Donald Johnsey |
Cao, Yin |
Washington University
United States |
Obesity, sedentary behaviors, and diet quality for prevention and early detection of early-onset colorectal neoplasia |
5R37CA246175-04 |
|
|
Mallery, Susan R |
Ohio State University
United States |
Assessment of Chemopreventive Effects of a Mucoadhesive Fenretinide Patch on Premalignant Oral Epithelial Lesions |
5R01CA227273-05 |
|
|
Li, Feng |
University Of California Los Angeles
United States |
Novel ultra-short cell free DNA biomarkers for early detection of non-small cell lung cancer. |
1R21CA283665-01 |
|
|
Alambeigi, Farshid |
University Of Texas At Austin
United States |
A Novel Framework for Sensitive and Reliable Early Diagnosis, Topographic Mapping, and Stiffness Classification of Colorectal Cancer Polyps |
1R21CA280747-01A1 |
|
Matthew Young, Ph.D. |
Flory, James H |
Sloan-Kettering Inst Can Research
United States |
Managing metabolic disruption in pancreatic cancer to prevent weight loss and improve quality of life |
1R21CA277464-01A1 |
|
Sharon Ross, Ph.D., M.P.H. |
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Carter, Bob S |
Massachusetts General Hospital
United States |
Standardized Molecular Analyses of Glioma EVs |
5R01CA237500-04 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Winters-Stone, Kerri M |
Oregon Health & Science University
United States |
Patterns and predictors of symptoms, falls, and functioning across treatment and recovery in patients treated with neurotoxic chemotherapy for cancer |
5R01CA248059-04 |
|
Goli Samimi, Ph.D., M.P.H. |
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Forsberg, Flemming |
Thomas Jefferson University
United States |
Prostate Cancer Diagnosis by Multiparametric Ultrasound |
5R01CA252311-04 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Zheng, Yingye |
Fred Hutchinson Cancer Center
United States |
Statistical Methods for Prospective Evaluation of Biomarkers |
5R01CA236558-14 |
|
Nick Hodges, Ph.D. |
Sieren, Jessica C |
University Of Iowa
United States |
Lung cancer screening efficacy enhanced through radiomic and epigenetic biomarkers |
5R01CA267820-02 |
|
Nick Hodges, Ph.D. |
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
Chung, Ki Young |
Prisma Health - Upstate
United States |
NCORP of the Carolinas (Greenville Health System NCORP) |
6UG1CA189972-10 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
Lad, Thomas |
Hektoen Institute For Medical Research
United States |
Stroger Hospital of Cook County (SHCC) MU-NCORP Renewal |
5UG1CA190000-10 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
Suga, Jennifer Marie |
Kaiser Foundation Research Institute
United States |
Kaiser Permanente NCI National Community Oncology Research Program, NCORP |
5UG1CA189821-10 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
Rowland, Kendrith Martin |
Carle Foundation
United States |
Carle Cancer Center NCI Community Oncology Research Program (NCORP) |
5UG1CA189861-10 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
Caywood, Emi H |
Alfred I. Du Pont Hosp For Children
United States |
Nemours NCI Community Oncology Research Program (NCORP) |
5UG1CA189958-10 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
Saphner, Thomas J |
Aurora Health Care, Inc.
United States |
Aurora NCORP Community Site |
5UG1CA190140-10 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
Halmos, Balazs |
Montefiore Medical Center (Bronx, Ny)
United States |
MINORITY-BASED COMMUNITY ONCOLOGY PROGRAM |
5UG1CA189859-10 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
Paskett, Electra D. |
Alliance Nctn Foundation
United States |
Alliance NCORP Research Base - BIQSFP GY10 Supplements |
3UG1CA189823-10S1 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
Gross, Howard M |
Dayton Clinical Oncology Program
United States |
Dayton Clinical Oncology Program |
5UG1CA189957-10 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
Langevin, Anne-Marie R. |
University Of Texas Hlth Science Center
United States |
Texas Pediatric NCORP MU |
5UG1CA189855-10 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
Chow, H-H. Sherry |
University Of Arizona
United States |
University of Arizona Cancer Prevention Clinical Trials Network (UA CP-CTNet) |
5UG1CA242596-05 |
RFA-CA-18-029 (UG1 Clinical Trial Required) |
Donald Johnsey |
Lesser, Glenn J |
Wake Forest University Health Sciences
United States |
Wake Forest NCORP Research Base |
5UG1CA189824-10 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
Curtis, Amarinthia E |
Spartanburg Regional Medical Center
United States |
Upstate Carolina Consortium - Community Oncology Research Program |
5UG1CA239762-05 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
Baghdadi, Tareq Al |
Saint Joseph Mercy Health System
United States |
Michigan Cancer Research Consortium NCORP |
5UG1CA189971-10 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
Milanovich, Samuel J |
Sanford Research/Usd
United States |
Sanford Community Cancer Program of the North Central Plains (NCORP) |
5UG1CA189825-10 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
Pollock, Brad H |
Public Health Institute
United States |
Children's Oncology Group NCI Community Oncology Research Program (NCORP) Research Base Grant |
3UG1CA189955-10S2 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
Schallenkamp, John M. |
Montana Cancer Consortium
United States |
Montana Cancer Consortium: An Inclusive and Collaborative Approach to Clinical Trial Accrual and Cancer Care Delivery Research across Montana, Idaho and Wyoming |
5UG1CA189872-10 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
Remick, Scot C |
Mainehealth
United States |
MaineHealth Cancer Care Network (MHCCN) and NCORP Activities across the Lifespan |
5UG1CA239771-05 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
Yost, Kathleen J |
Spectrum Health Hospitals
United States |
Cancer Research Consortium of West Michigan (CRCWM) |
5UG1CA189860-10 |
|
|
Santos-Reyes, Luis Javier |
Comprehensive Cancer Center/ Univ/Pr
United States |
Puerto Rico Minority Underserved NCI Community Oncology Research Program (Puerto Rico MUNCORP) |
5UG1CA189862-10 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
Vinciguerra, Vincent P |
Feinstein Institute For Medical Research
United States |
Northwell Health NCORP |
5UG1CA189850-10 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
Bruner, Deborah Watkins |
Nrg Oncology Foundation, Inc.
United States |
NRG Oncology NCORP Research Base |
5UG1CA189867-10 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
Blanke, Charles D. |
Oregon Health & Science University
United States |
Cancer Disparity Collaborative Supplement: Integrating electronic health record and patient-generated health data for breast cancer and cardiovascular disease risk assessment among diverse multiet... |
3UG1CA189974-10S1 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
Cantuaria, Guilherme |
Northside Hospital Atlanta
United States |
Georgia NCI Community Oncology Research Program (GA NCORP) |
5UG1CA189997-10 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
Carlson, Jay W |
Ozark Health Ventures, Llc
United States |
Ozark Health Ventures LLC dba Cancer Research for the Ozarks (CRO) |
5UG1CA189822-10 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
Berenberg, Jeffrey Lee |
University Of Hawaii At Manoa
United States |
The Hawaii Minority/Underserved NCORP |
5UG1CA189804-10 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
Ellerton, John A |
Southern Nevada Cancer Research Fdn
United States |
NCI Community Oncology Research Program (NCORP) Community Sites (UG1 Clinical Trial Required) |
5UG1CA189829-10 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
Faller, Bryan |
Decatur Memorial Hospital
United States |
Heartland Cancer Research NCORP |
5UG1CA189830-10 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
Friday, Bret E.B. |
Essentia Institute Of Rural Health
United States |
Essentia Health Community Cancer Research Program - NCORP |
5UG1CA189812-10 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
Drescher, Charles |
Swedish Medical Center, First Hill
United States |
The Pacific Cancer Research Consortium (PCRC), an NCORP Community Site |
5UG1CA189953-10 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
Md, Nicholas Dibella |
Western States Cancer Research Ncorp
United States |
Western States Cancer Research NCORP |
5UG1CA189805-10 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
Matin, Khalid |
Virginia Commonwealth University
United States |
VCU Massey Cancer Center Minority/Underserved NCI Community Oncology Research Program |
5UG1CA189869-10 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
Doolittle, Gary C. |
University Of Kansas Medical Center
United States |
The University of Kansas Cancer Center's- MCA Rural NCORP |
5UG1CA239767-05 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
Williams, Paige L |
Harvard School Of Public Health
United States |
Pediatric HIV/AIDS Cohort Study (PHACS) 2020 |
5P01HD103133-04 |
|
|
Onitilo, Adedayo A |
Marshfield Clinic Research Foundation
United States |
Wisconsin NCI Community Oncology Research Program (WiNCORP) |
5UG1CA189956-10 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
Kachnic, Lisa A. |
Columbia University Health Sciences
United States |
Columbia University Minority/Underserved Site NCI Community Oncology Research Program |
5UG1CA189960-10 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
Salman, Emad |
Florida Assn Of Pediatric Tumor Prog
United States |
The Florida Pediatric NCORP renewal application for grant# UG1CA189973 to continue participation in the NCI Community Oncology Research Program. |
5UG1CA189973-10 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
Ghamande, Sharad A. |
Augusta University
United States |
Georgia CaRes |
5UG1CA189851-10 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
Panikkar, Rajiv |
Geisinger Clinic
United States |
Geisinger Cancer Institute - NCI Community Oncology Research Program (NCORP) |
5UG1CA189847-10 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
Muller, Carolyn Y |
University Of New Mexico Health Scis Ctr
United States |
NCI Community Oncology Research Program (NCORP) Minority/Underserved Community Sites |
5UG1CA189856-10 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
Irvin, William J |
Southeast Clinical Oncol Res Consortium
United States |
NCI Community Oncology Research Program (NCORP) Community Sites (UG1 Clinical Trial Required) |
5UG1CA189858-10 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
Masters, Gregory A |
Christiana Care Health Services, Inc.
United States |
Delaware Christiana Care NCORP |
5UG1CA189819-10 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
Whitman, Eric |
Atlantic Health System, Inc.
United States |
The Atlantic Health Cancer Consortium Community Oncology Research Program (AHCC CORP) |
5UG1CA239772-05 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
Adams-Campbell, Lucile Lauren |
Georgetown University
United States |
National Capital Area (NCA) Minority/Underserved NCORP |
5UG1CA239758-05 |
|
|
Osarogiagbon, Raymond U |
Baptist Memorial Hospital - Tipton
United States |
Baptist Memorial Health Care/Mid South NCORP Minority Underserved Consortium |
5UG1CA189873-10 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
Jaslowski, Anthony J |
St. Vincent Hospital
United States |
Cancer Research of Wisconsin and Northern Michigan (CROWN) Consortium |
5UG1CA239769-05 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
Anderson, Daniel M |
Healthpartners Institute
United States |
Metro-Minnesota Community Oncology Research Consortium (MMCORC) |
5UG1CA189863-11 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
Bailey, Lisa (Nmn) |
Bay Area Tumor Institute
United States |
Bay Area Tumor Institute NCI Community Oncology Research Program (NCORP) Community Sites |
5UG1CA189817-10 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
Marshall, David T. |
Medical University Of South Carolina
United States |
Medical University of South Carolina NCORP Minority/Underserved Community Site |
5UG1CA189848-10 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
Siddique, Shahzad |
Commonspirit Health Research Institute
United States |
CIRI Oncology Research Alliance |
5UG1CA189809-10 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
Lukenbill, Joshua Cole |
Iowa Oncology Research Association
United States |
Iowa-Wide Oncology Research Coalition (I-WORC) |
5UG1CA189816-10 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
Khan, Seema Ahsan |
Northwestern University At Chicago
United States |
Northwestern Cancer Prevention Consortium |
5UG1CA242643-05 |
RFA-CA-18-029 (UG1 Clinical Trial Required) |
Donald Johnsey |
Wagner, Lynne I. |
Ecog-Acrin Medical Research Foundation
United States |
ECOG-ACRIN NCORP Research Base - TMIST |
3UG1CA189828-10S1 |
|
|
Moore, Timothy David |
Columbus Community Clinical Oncology Prg
United States |
Columbus NCORP RFA-CA-18-016 |
5UG1CA189954-10 |
|
|
Paus, Ralf |
University Of Miami School Of Medicine
United States |
Pre-clinical testing of low intensity ultrasound as novel strategy to prevent paclitaxel-induced hair follicle damage in a humanized mouse model of chemotherapy-induced alopecia |
1R21CA277418-01A1 |
|
Rachel Altshuler, Ph.D. |
Wilkin, Timothy J |
Weill Medical Coll Of Cornell Univ
United States |
Partnership for Prevention of HPV-Associated Cancers in People Living with HIV: Brazil, Mexico, and Puerto Rico |
5U54CA242639-05 |
|
Silvina Frech, Ph.D., M.S. |
Palefsky, Joel Michael |
University Of California, San Francisco
United States |
California-Mexico-Puerto Rico Partnership (CAMPO) Center for Prevention of HPV-related Cancer in HIV+ Populations |
3U54CA242646-05S1 |
|
Silvina Frech, Ph.D., M.S. |
Madeleine, Margaret M |
Fred Hutchinson Cancer Center
United States |
Colaboracion Evita: HPV-Related Cancer Prevention Partnership Center |
5U54CA242977-06 |
|
Silvina Frech, Ph.D., M.S. |
Vilar-Sanchez, Eduardo |
University Of Tx Md Anderson Can Ctr
United States |
iCAN-PREVENT: MD Anderson International Cancer Prevention Clinical Trial Consortium |
5UG1CA242609-05 |
|
Donald Johnsey |
Barroilhet, Lisa M |
University Of Wisconsin-Madison
United States |
The MW Cancer Prevention Clinical Trials Network |
5UG1CA242635-04 |
|
Donald Johnsey |
Wang, Thomas D |
University Of Michigan At Ann Arbor
United States |
Early detection of colorectal cancer in the traditional and serrated pathways |
5R01CA249851-04 |
PAR-19-264 (R01 Clinical Trial Optional) |
|
Sariol, Carlos A |
University Of Puerto Rico Med Sciences
United States |
SARS-CoV-2 correlates of protection in a Latino-origin population |
3U01CA260541-02S1 |
|
Guillermo Marquez, Ph.D. |
Ahn, Jiyoung |
New York University School Of Medicine
United States |
The Oral Mycobiome and Risk of Pancreatic Cancer |
5U01CA250186-03 |
PAR-18-913 (U01 Clinical Trial Not Allowed) |
|
Hundley, William Gregory |
Wake Forest University Health Sciences
United States |
Improving Exercise Capacity with a Tailored Physical Activity Intervention in Lymphoma Patients Undergoing Treatment |
5R33CA226960-04 |
|
Eileen Dimond, R.N., M.S. |
Wang, Tza-Huei Jeff |
Johns Hopkins University
United States |
A low-cost, multiplexed digital high resolution melt platform for DNA methylation-based detection and identification of cancers in liquid biopsies |
5R33CA272321-02 |
|
|
Elias, Kevin |
Brigham And Women'S Hospital
United States |
Ovarian cancer risk stratification using circulating miRNAs to assess BRCAness |
1R03CA283252-01 |
|
Christos Patriotis, Ph.D., M.Sc. |
Shuck, Sarah C. |
Beckman Research Institute/City Of Hope
United States |
Identification of metabolic adducts associated with prostate cancer progression in African American men |
1R21CA282612-01 |
|
Guillermo Marquez, Ph.D. |
Counter, Christopher M |
Duke University
United States |
Adapting K-MDS to detect KRAS-mutant ctDNA |
5R21CA257816-02 |
|
|
Li, Chi |
University Of Louisville
United States |
A lung cancer vaccine based on exosomes of induced pluripotent stem cells |
1R21CA280453-01 |
|
John Clifford, Ph.D. |
Wang, Jing |
New York University School Of Medicine
United States |
Optimizing the use of ketamine to reduce chronic postsurgical pain |
5UH3CA261067-04 |
|
|
Albertson, Donna G |
New York University
United States |
Artemin overexpression in oral cancer pain and carcinogenesis |
5R01CA228525-05 |
|
Rachel Altshuler, Ph.D. |
Wilson, Michael R |
Wayne State University
United States |
Does obesity influence protein quality control in endometrial cancer? |
5R00CA252152-04 |
|
|
Bao, Ting |
Dana-Farber Cancer Inst
United States |
Acupuncture for Chemothrapy-induced Peripheral Neuropathy Treatment (ACT) Trial |
7R37CA248563-04 |
|
|
Elenitoba-Johnson, Kojo S. J. |
Sloan-Kettering Inst Can Research
United States |
Genomic biomarkers of splenic lymphoma |
5R01CA255655-05 |
|
|
Wang, Hsiao-Lan |
University Of Alabama At Birmingham
United States |
A Motion Exergaming Approach to Promote Self-Managing Fatigue and Pain after Head and Neck Cancer Treatment |
5R01CA244947-05 |
|
|
Storz, Peter |
Mayo Clinic Jacksonville
United States |
Deiminated molecules as markers for developing pancreatic cancer - A1 |
1R21CA279916-01A1 |
|
|
Li, Bing |
University Of Iowa
United States |
E-FABP mediates n-3 fatty acid-induced tumor prevention through epigenetic control of immune cell differentiation and function |
5R01CA180986-10 |
|
|
Fitzgibbon, Marian L |
University Of Illinois At Chicago
United States |
Mediterranean Diet and Weight Loss: Targeting the Bile Acid/Gut Microbiome Axis to Reduce Colorectal Cancer Risk |
5R01CA250390-04 |
|
|
Fuschiotti, Patrizia |
University Of Pittsburgh At Pittsburgh
United States |
Develop IL13Ra1 for diagnosis of early-stage mycosis fungoides |
1R21CA280445-01A1 |
|
Wendy Wang, Ph.D., M.Sc. |
Phillips, Nicholas S |
St. Jude Children'S Research Hospital
United States |
Cardiopulmonary function and cerebral blood flow in Hodgkin Lymphoma survivors |
1R21CA280230-01A1 |
|
Eileen Dimond, R.N., M.S. |
Tollefsbol, Trygve O |
University Of Alabama At Birmingham
United States |
Combinatorial epigenetic-based prevention of breast cancer |
5R01CA178441-09 |
|
|
Zhu, Yazhen |
University Of California Los Angeles
United States |
Extracellular Vesicle-Based Digital Scoring Assay for Detecting Early-stage Hepatocellular Carcinoma |
5R01CA255727-04 |
|
|
Maldonado, Fabien |
Vanderbilt University Medical Center
United States |
Novel Integrative Approach for the Early Detection of Lung Cancer using Repeated Measures |
5R01CA253923-04 |
|
|
Welsh, Joellen |
State University Of New York At Albany
United States |
Vitamin K: Body Pools and Function in Breast Cancer |
5R01CA258231-04 |
PA-20-185 (Parent R01 Clinical Trial Not Allowed) |
|
Palesh, Oxana G |
Virginia Commonwealth University
United States |
Multicenter Randomized Controlled Trial of Brief Behavioral Therapy for Cancer Related Insomnia |
5R01CA239714-06 |
|
Marge Good, R.N., M.P.H., O.C.N. |
Lokshin, Anna E |
University Of Pittsburgh At Pittsburgh
United States |
Urine and serum biomarkers for early diagnosis and risk assessment of pancreatic cancer |
5R01CA254036-04 |
|
|
Wei, Lei |
Roswell Park Cancer Institute Corp
United States |
Advancing skin cancer prevention by tackling UV-induced clonogenic mutations |
5R01CA255242-04 |
|
|
Xiao, Yi |
University Of Tx Md Anderson Can Ctr
United States |
Exploring new strategy for breast cancer immunoprevention by targeting histamine receptor H1 |
1R21CA286318-01 |
|
Anda Vlad, M.D., Ph.D. |
Barber, Glen N. |
University Of Miami School Of Medicine
United States |
Development of A HTLV-1 Vaccine |
5R01CA252049-04 |
PA-20-185 (Parent R01 Clinical Trial Not Allowed) |
|
Nolan, Michael Warren |
North Carolina State University Raleigh
United States |
Evaluation of TRPM8-expressing neurons as novel regulators of acute radiotherapy-associated pain in patients with head and neck cancer |
5R37CA248797-04 |
|
|
Deng, Gary E |
Sloan-Kettering Inst Can Research
United States |
Acupuncture to Improve Outcomes in Patients with Sepsis: a Randomized Controlled Trial |
1R21CA286330-01 |
|
Goli Samimi, Ph.D., M.P.H. |
Terry, Kathryn L |
Brigham And Women'S Hospital
United States |
Changing Contraceptive Patterns and Ovarian Cancer Risk |
5R01CA258679-03 |
PA-20-185 (Parent R01 Clinical Trial Not Allowed) |
|
Godwin, Andrew K. |
University Of Kansas Medical Center
United States |
Extracellular Vesicle Proteomic Fingerprinting of Ovarian Cancer for Early Detection with a Nanoengineered Microsystem |
3R01CA260132-03S1 |
|
|
Bao, Ting |
Dana-Farber Cancer Inst
United States |
Yoga for Chemotherapy-induced Peripheral Neuropathy Treatment (YCT) Trial |
5R01CA251470-05 |
|
|
Chan, Andrew T |
Massachusetts General Hospital
United States |
Effects of inflammaging on intestinal epithelial cells and aspirin chemoprevention. |
5R01CA257523-03 |
|
|
Schmidt, Christian Maximillian |
Indiana Univ-Purdue Univ At Indianapolis
United States |
Longitudinal Proteomic and Metabolomic Predictors of Pancreatic Cyst Malignant Progression and Early Stage Pancreatic Cancer |
5U01CA239522-04 |
PAR-18-913 (U01 Clinical Trial Not Allowed) |
|
Dhakal, Soma |
Virginia Commonwealth University
United States |
Single-Molecule High-Confidence Detection of miRNA Cancer Biomarkers |
5R61CA278445-02 |
|
|
Spiegel, Brennan |
Cedars-Sinai Medical Center
United States |
Randomized Controlled Trial of Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes |
5R01CA252211-03 |
|
Rachel Altshuler, Ph.D. |
Jiang, Feng |
University Of Maryland Baltimore
United States |
Plasma biomarkers for lung cancer diagnosis |
4UH3CA251139-03 |
|
|
Tayob, Nabihah |
Dana-Farber Cancer Inst
United States |
Biomarker screening algorithms for the improved early detection of hepatocellular carcinoma |
5R01CA230503-06 |
|
|
Pozdeyev, Nikita |
University Of Colorado Denver
United States |
Genetic architecture of thyroid cancer and its clinical utility |
1R21CA282380-01A1 |
|
|
Webster, Nicholas J |
Veterans Medical Research Fdn/San Diego
United States |
The Effect of Time-Restricted Eating on the Efficiency of Chemo- and Hormonal-Therapy in Breast Cancer |
1R21CA288777-01 |
|
|
Song, Ming |
University Of Louisville
United States |
Dietary fructose and NASH/HCC progression |
1R21CA290420-01 |
|
|
Jiang, Qing |
Purdue University
United States |
Anti-cancer effects of tocotrienols and a carboxychromanol in an innovative colon cancer model |
1R03CA283236-01A1 |
|
|
Rosenberg, Daniel William |
University Of Connecticut Sch Of Med/Dnt
United States |
Microbiota, Metabolites, and Colon Neoplasia |
5R01CA252045-03 |
PA-18-902 (R01 Clinical Trial Optional) |
|
Livneh, Zvi |
Weizmann Institute Of Science
United States |
Analysis of the predictability of lung cancer using DNA Repair functional assays and cryopreserved blood samples of the PLCO prospective cohort |
1U01CA279001-01 |
|
Claire Zhu, Ph.D. |
Liu, Yang |
University Of Pittsburgh At Pittsburgh
United States |
Imaging nanoscale chromatin folding in early carcinogenesis |
5R01CA254112-04 |
|
|
Carson, Tiffany Lashaun |
H. Lee Moffitt Cancer Ctr & Res Inst
United States |
Determining the structural- and functional-level effects of diet-specific interventions on the gut microbiota of a diverse sample of Southern United States adults |
5R01CA253219-04 |
|
|
Bertozzi, Carolyn |
Stanford University
United States |
Chemical Glycoproteomics |
5R01CA200423-20 |
PA-20-185 (Parent R01 Clinical Trial Not Allowed) |
|
Boyer, Thomas G |
University Of Texas Hlth Science Center
United States |
Pathological reprogramming of the m6A epitranscriptome in uterine fibroids |
5R01HD106285-03 |
|
|
Wang, Tza-Huei Jeff |
Johns Hopkins University
United States |
Development of a low-cost epigenetic screening assay for Pap specimen-based detection of early-stage ovarian cancer in high-risk women |
5R01CA260628-03 |
PA-20-185 (Parent R01 Clinical Trial Not Allowed) |
|
Hanks, Brent Allen |
Duke University
United States |
Role of the tumor NLRP3 inflammasome in the generation of anti-PD-1 antibody immunotherapy-associated toxicities |
5R01CA251136-03 |
PAR-19-325 (R01 Clinical Trial Optional) |
Marjorie Perloff, M.D. |
Kong, Mei |
University Of California-Irvine
United States |
Using dietary glutamine supplementation for melanoma prevention and targeted therapy |
5R01CA244360-03 |
PA-20-185 (Parent R01 Clinical Trial Not Allowed) |
|
Hitchins, Megan P |
Cedars-Sinai Medical Center
United States |
Discovery and verification of methylated circulating tumor DNA markers for the detection of colorectal cancer in subjects under 50 years of age |
5R01CA252042-03 |
PA-20-185 (Parent R01 Clinical Trial Not Allowed) |
|
Lubman, David M |
University Of Michigan At Ann Arbor
United States |
Serum Glyco-Markers of Early Hepatocellular Carcinoma Using a Mass Spec Approach |
5R01CA160254-12 |
|
|
Acciavatti, Raymond Joseph |
University Of Pennsylvania
United States |
Next-Generation Tomosynthesis Pilot Study |
5R37CA273959-02 |
|
|
Djuric, Zora |
University Of Michigan At Ann Arbor
United States |
MyGI Diet for Colorectal Cancer Prevention |
5R01CA255743-03 |
|
|
Cohn, Barbara A |
Public Health Institute
United States |
Discriminatory Mechanisms in Early-Onset and Lethal Prostate Cancer |
5R01CA264519-03 |
|
Howard L. Parnes, M.D. |
Washington, Karla |
Washington University
United States |
Problem-Solving Therapy for Cancer Caregivers: A Randomized Clinical Trial in Outpatient Palliative Care |
3R01CA258311-03S1 |
|
|
Yendamuri, Saikrishna |
Roswell Park Cancer Institute Corp
United States |
Metformin for chemoprevention of lung cancer in obese subjects at high risk |
3R01CA255515-03S1 |
|
|
Hur, Chin |
Columbia University Health Sciences
United States |
Optimal Colorectal Cancer Surveillance Strategy for Lynch Syndrome by Genotype |
5R01CA257333-03 |
PA-20-185 (Parent R01 Clinical Trial Not Allowed) |
|
Skubitz, Amy Patrice |
University Of Minnesota
United States |
A paradigm shift for ovarian cancer biomarkers: Utilizing routine Pap tests as liquid biopsies for the development of targeted mass spectrometry-based proteomic assays for early detection |
5R01CA262153-03 |
PA-20-185 (Parent R01 Clinical Trial Not Allowed) |
|
Shalon, Tidhar Dari |
Envivo Bio Inc
United States |
Development and clinical evaluation of the CapScan gastrointestinal sampling device for metabolomics monitoring |
4R33CA260665-02 |
|
Sharon Ross, Ph.D., M.P.H. |
Khasabov, Sergey G |
University Of Minnesota
United States |
Treatment of cancer pain by lipid mediator Resolvin D1: role of Prostaglandin and Endocannabinoid signaling |
5R01CA263777-03 |
|
Rachel Altshuler, Ph.D. |
Fabian, Carol J |
University Of Kansas Medical Center
United States |
Biomarker-Based Phase IIB Trial of (Bazedoxifene-Conjugated Estrogen) to Reduce Risk for Breast Cancer |
5R01CA249437-03 |
|
Edward Sauter, M.D., Ph.D. |
Sigel, Keith Magnus |
Icahn School Of Medicine At Mount Sinai
United States |
The effectiveness of screening women with lower genital tract neoplasia or cancers for anal cancer precursors |
5R01CA256660-03 |
|
|
Metzger, Gregory John |
University Of Minnesota
United States |
Computer Aided Diagnostic System for Prostate Cancer Detection Using Quantitative Multiparametric MRI |
5R01CA241159-03 |
|
|
Marchand, Loic Le |
University Of Hawaii At Manoa
United States |
Effects of Intermittent Energy Restriction on Intra-Abdominal Fat and the Gut Microbiome: A Randomized Trial |
5R01CA258179-03 |
RFA-CA-20-004 (R01 Clinical Trial Optional) |
|
Ondrey, Frank G. |
University Of Minnesota
United States |
Pioglitazone-Metformin Combination Treatment for High Risk Oral Preneoplasia |
5R01CA254270-02 |
PAR-21-035 (R01 Clinical Trial Required) |
|
Panda, Satchidananda |
Salk Institute For Biological Studies
United States |
Impact of Time-Restricted Feeding in Reducing Cancer Risk Through Optimizing Mitochondria Function |
3R01CA258221-03S1 |
RFA-CA-20-004 (R01 Clinical Trial Optional) |
|
Schmit, Stephanie L |
Cleveland Clinic Lerner Com-Cwru
United States |
Variation in tumor-associated immune profiles and colorectal cancer outcomes |
5R01CA248931-03 |
|
|
Hecht, Stephen S |
University Of Minnesota
United States |
High resolution mass spectrometric profile analysis of carcinogen-DNA adducts in oral cells of cigarette smokers and squamous cell carcinoma of the head and neck |
5R01CA263084-03 |
PA-20-185 (Parent R01 Clinical Trial Not Allowed) |
|
Ulrich, Cornelia M |
University Of Utah
United States |
Adipose tissue-colorectal tumor cross-talk: new targets for breaking the obesity-cancer link |
5R01CA254108-03 |
PA-20-185 (Parent R01 Clinical Trial Not Allowed) |
|
Tussing-Humphreys, Lisa |
University Of Illinois At Chicago
United States |
Mediating Role of Gut Microbiota in the Regulation of Colorectal Cancer Risk in the Context of Time-restricted Eating and Calorie Restriction |
3R01CA257807-03S1 |
RFA-CA-20-004 (R01 Clinical Trial Optional) |
|
Skates, Steven J |
Massachusetts General Hospital
United States |
Proteomic Analyses of Serial Prediagnostic PLCO Serum in Cases and Controls to Identify Early Detection Ovarian Cancer Biomarkers Rising in a Substantial Fraction of Cases and Stable in Most Controls |
5U01CA260758-03 |
PAR-18-913 (U01 Clinical Trial Not Allowed) |
|
Li, Debiao |
Cedars-Sinai Medical Center
United States |
Predicting Pancreatic Ductal Adenocarcinoma (PDAC) Through Artificial Intelligence Analysis of Pre-Diagnostic CT Images |
5R01CA260955-03 |
PA-20-185 (Parent R01 Clinical Trial Not Allowed) |
|
Park, Youngkyu |
Cold Spring Harbor Laboratory
United States |
Preclinical Models for Cancer Therapeutic Development |
5R50CA211506-08 |
|
|
Labaer, Joshua |
Arizona State University-Tempe Campus
United States |
Multiplex In-Solution Protein Array (MISPA) for high throughput, quantitative, early profiling of pathogen-induced head and neck |
1R33CA281802-01 |
|
|
Vilar-Sanchez, Eduardo |
University Of Tx Md Anderson Can Ctr
United States |
Cancer Immune-Interception for Lynch Syndrome |
5R01CA257375-03 |
|
|
Mungo, Chemtai Chemtai |
Univ Of North Carolina Chapel Hill
United States |
Feasibility of artesunate to improve HPV and cervical precancer treatment outcomes among HIV positive women in LMICs |
1R34CA284983-01 |
|
Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H. |
Zarrinpar, Amir |
University Of California, San Diego
United States |
Engineering Native E. coli to Detect, Report, and Treat Colorectal Cancer |
5U01CA265719-03 |
|
|
Kahalley, Lisa Schum |
Baylor College Of Medicine
United States |
Comparison of Symptom Burden/Toxicity, Neurocognitive Change, and Functional Outcomes in Pediatric Brain Tumor Patients Treated with Proton vs. Photon Radiotherapy. |
3R01CA249988-03S1 |
|
|
Yang, Wan |
Columbia University Health Sciences
United States |
UNCOVER: underlying novel causes of onset of very early cancer research |
5R01CA257971-03 |
|
Nick Hodges, Ph.D. |
Kroetz, Deanna L |
Ohio State University
United States |
Sphingolipid Signaling and Chemotherapy-Induced Peripheral Neurotoxicity |
5R01CA261068-05 |
|
|
Tanasova, Marina |
Michigan Technological University
United States |
Molecular probes for targeting facilitative fructose transporters (GLUTs) in biochemical and biomedical applications |
2R15CA242401-02A1 |
|
|
Peppone, Luke Joseph |
University Of Rochester
United States |
High-dose Vitamin D Supplementation for ADT-Induced Bone Loss in Older Prostate Cancer Patients |
5R01CA258349-03 |
PAR-21-035 (R01 Clinical Trial Required) |
|
Sempere, Lorenzo |
Michigan State University
United States |
Image-Guided Intraductal Ablative Procedure for Primary Prevention of Breast Cancer |
5R01CA258314-03 |
|
Edward Sauter, M.D., Ph.D. |
Goncalves, Marcus Dasilva |
Weill Medical Coll Of Cornell Univ
United States |
Molecular Mechanisms of Fructose-induced Colorectal Cancer Cell Survival |
5R01CA258697-03 |
PA-20-185 (Parent R01 Clinical Trial Not Allowed) |
|
Geisler, Stefanie |
Washington University
United States |
Developing mechanism-based strategies to treat chemotherapy-induced peripheral neuropathy |
5R37CA267905-03 |
PAR-19-325 (R01 Clinical Trial Optional) |
|
Ibsen, Stuart Duncan |
Oregon Health & Science University
United States |
Distinguishing Pancreatic Cancer from Benign Pancreatic Disease using Nanoparticle-based Biomarkers |
5R37CA258787-03 |
PAR-20-053 (R01 Clinical Trial Not Allowed) |
|
Shureiqi, Imad |
University Of Michigan At Ann Arbor
United States |
ALOX15 regulation of colon cancer invasiveness via PI3P-linoleic acid metabolism |
5R01CA266223-03 |
PA-20-185 (Parent R01 Clinical Trial Not Allowed) |
|
Suter, Melissa J |
Massachusetts General Hospital
United States |
Early Detection and Diagnosis of Lung Cancer with Endomicroscopy |
5R01CA255326-02 |
|
Guillermo Marquez, Ph.D. |
Nicolson, Fay |
Dana-Farber Cancer Inst
United States |
SESORRS endoscopy for the staging and evaluation of colorectal cancer |
4R00CA266921-03 |
|
Gary Della'Zanna, D.O., M.Sc. |
Maclean, Paul S. |
University Of Colorado Denver
United States |
Novel dietary interventions for reducing obesity-associated breast cancer |
5R01CA258766-03 |
|
|
Barton, Jennifer Kehlet |
University Of Arizona
United States |
Ovarian Cancer Detection with Blood- and Imaging-Based Biomarkers |
3R01CA260399-03S1 |
|
|
Stolley, Melinda R |
Medical College Of Wisconsin
United States |
Every Day Counts: A lifestyle program for women metastatic breast cancer |
5R01CA258759-03 |
PAR-18-893 (R01 Clinical Trial Optional) |
|
Sherman, Mark E |
Mayo Clinic Jacksonville
United States |
Targeted Prevention of Postpartum-Related Breast Cancer (PRBC) |
5R01CA262393-03 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
Beretta, Laura |
University Of Tx Md Anderson Can Ctr
United States |
Early Detection of Hepatocellular Carcinoma |
5R01CA195524-08 |
PAR-19-264 (R01 Clinical Trial Optional) |
|
Cremer, Miriam |
Cleveland Clinic Lerner Com-Cwru
United States |
Development of an HPV stigma assessment scale and a stigma-reducing intervention to improve cervical cancer prevention in El Salvador |
3R01CA266059-02S1 |
|
|
Huberty, Jennifer Lynne |
University Of Texas Hlth Science Center
United States |
Consumer-based meditation app, Calm, for treatment of sleep disturbance in hematological cancer patients |
5R01CA262041-03 |
|
|
Meghani, Salimah H. |
University Of Pennsylvania
United States |
Cannabis use and outcomes in ambulatory patients with cancer: A 12-month cohort study |
3R01CA270483-02S1 |
PA-18-917 (R01 - Clinical Trial Optional) |
Sharon Ross, Ph.D., M.P.H. |
Watt, Gordon Patrick |
Sloan-Kettering Inst Can Research
United States |
Quantitative background parenchymal enhancement, measured on contrast-enhanced mammogram, as a novel marker of breast cancer risk |
1R37CA284134-01A1 |
|
|
Liu, Changchun |
University Of Connecticut Sch Of Med/Dnt
United States |
Low-Cost CRISPR-on-Paper for Cervical Cancer Screening at the Point of Care |
5U01CA269147-02 |
|
|
Clapper, Margie L. |
Research Inst Of Fox Chase Can Ctr
United States |
Folic Acid Supplementation and Colitis-associated Colon Carcinogenesis |
5R01CA262551-02 |
PA-20-185 (Parent R01 Clinical Trial Not Allowed) |
|
Grogan, Eric L |
Vanderbilt University Medical Center
United States |
Clinical Utility of Biomarkers Driven Management of Indeterminate Pulmonary Nodules |
5R01CA252964-03 |
|
|
Saenger, Yvonne Margaret |
Albert Einstein College Of Medicine
United States |
Applying pathomics to establish a biosignature for aggressive skin melanoma |
5R01CA260375-03 |
|
|
Wallace, Douglas C |
Children'S Hosp Of Philadelphia
United States |
Anti-tumor immunity and intestinal microbiota are modulated by mitochondrial DNA |
5R01CA259635-02 |
PAR-19-198 (R01 Clinical Trial Not Allowed) |
|
Ramanujam, Nirmala |
Duke University
United States |
Development and Validation of an Artificial-Intelligence-enabled Portable Colposcopy Device for Optimizing Triage Alternatives for HPV-based Cervical Cancer Screening |
5U01CA269192-02 |
|
|
Kolb, Noah Allan |
University Of Vermont & St Agric College
United States |
Remote Monitoring of Management of Chemotherapy induced Peripheral Neuropathy |
5R01CA247517-03 |
|
|
Mallery, Susan R |
Ohio State University
United States |
Formulation, Evaluation, and Phase 0 Trial of Nanoparticle Releasing Oral Thin Film for OSCC Chemoprevention |
5R01CA258757-02 |
PAR-21-035 (R01 Clinical Trial Required) |
Malgorzata (Margaret) Wojtowicz, M.D. |
Rini, Christine |
Northwestern University At Chicago
United States |
Web-based Pain Coping Skills Training to Improve Pain and Poor Adherence caused by Aromatase Inhibitor-Associated Arthralgia In Breast Cancer Survivors (SKIP-Arthralgia): A Randomized Controlled Trial |
5R01CA271220-02 |
PAR-21-035 (R01 Clinical Trial Required) |
|
Ameringer, Suzanne W |
Virginia Commonwealth University
United States |
A Randomized Controlled Trial using a Heuristic Tool To Improve Symptom Self-Management in Adolescents and Young Adults with Cancer |
1R01CA286799-01 |
|
Ellen Richmond, M.S., G.N.P.-B.C. |
Malafa, Mokenge P |
H. Lee Moffitt Cancer Ctr & Res Inst
United States |
Novel Therapy to Inhibit IPMN Progression |
5R01CA263575-02 |
|
|
Smith, Jennifer Susan |
Univ Of North Carolina Chapel Hill
United States |
UNC CASCADE Network Research Base |
5UG1CA275403-02 |
|
Silvina Frech, Ph.D., M.S. |
Siminski, Suzanne M. |
Frontier Sci & Technology Rsch Fdn, Inc
United States |
CASCADE Coordinating Center |
5U24CA275417-02 |
|
Silvina Frech, Ph.D., M.S. |
Winer, Rachel L. |
University Of Washington
United States |
The CASCADE CLIMB: Cervical cancer prevention in women Living with HIV research Mobilization Base |
5UG1CA275402-02 |
|
Silvina Frech, Ph.D., M.S. |
Adebamowo, Clement Adebayo |
University Of Maryland Baltimore
United States |
Baltimore CASCADE Study Site (BaCSS Project) |
1UG1CA284883-01 |
|
Silvina Frech, Ph.D., M.S. |
Flowers, Lisa C. |
Emory University
United States |
Georgia Consortium to Eliminate Cervical Cancer in Women Living with HIV (GaCECC-WLWH) |
1UG1CA284884-01 |
|
Silvina Frech, Ph.D., M.S. |
Chung, Michael Hoonbae |
Emory University
United States |
HIV/cervical cancer cOntrol and Prevention clinical sitE in Kenya (HOPE-Kenya) |
5UG1CA275400-02 |
|
Silvina Frech, Ph.D., M.S. |
Naicker, Nivashnee |
Centre/Aids Programme/Res/South Africa
United States |
CAPRISA CASCADE Clinical Trials Network Clinical Research Site |
1UG1CA284671-01 |
|
Silvina Frech, Ph.D., M.S. |
Wilkin, Timothy J |
Weill Medical Coll Of Cornell Univ
United States |
Partnership for advancing cervical cancer prevention in women living with HIV (CASCADE - Research Hub) |
5UG1CA275414-02 |
|
Silvina Frech, Ph.D., M.S. |
Chirenje, Zvavahera Mike |
University Of California, San Francisco
United States |
Implementing HIV/Cervical Cancer Prevention CASCADE Clinical Trials in Zimbabwe (ZIM-CASCADE) |
1UG1CA284918-01 |
|
Silvina Frech, Ph.D., M.S. |
Mugo, Nelly Rwamba |
Kenya Medical Research Institute (Kemri)
United States |
KEMRI-PHRD UG1 CASCADE NETWORK UNIT: CERVICAL CANCER PREVENTION FOR WOMEN LIVING WITH HIV RESEARCH |
1UG1CA285132-01 |
|
Silvina Frech, Ph.D., M.S. |
Mwesigwa, Betty |
Makerere University Walter Reed Project
United States |
Implementing HIV/Cervical Cancer Prevention CASCADE Clinical Trials in Uganda (CASCADE UGANDA) |
5UG1CA275412-02 |
|
Silvina Frech, Ph.D., M.S. |
Murenzi, Gad |
Research For Development
United States |
Rwanda CASCADE Clinical Trials Site for cervical cancer prevention |
1UG1CA284908-01 |
|
Silvina Frech, Ph.D., M.S. |
Dryden-Peterson, Scott Lee |
Brigham And Women'S Hospital
United States |
Botswana CASCADE Clinical Trials Site |
5UG1CA275416-02 |
|
Silvina Frech, Ph.D., M.S. |
Caulin, Carlos |
University Of Arizona
United States |
Genetic Alterations That Confer High Risk to Oral Premalignant Lesions |
5R01CA274857-02 |
PA-20-185 (Parent R01 Clinical Trial Not Allowed) |
|
Liang, Han |
University Of Tx Md Anderson Can Ctr
United States |
The Cancer Proteome Atlas: an Integrated Bioinformatics Resource for Functional Cancer Proteomic Data |
5U24CA264128-02 |
RFA-CA-21-015 (U24 Clinical Trial Optional) |
|
Huang, Ying |
Western University Of Health Sciences
United States |
Preventing UV-induced immunosuppression and skin carcinogenesis with R-carvedilol |
5R01CA269653-02 |
PA-20-185 (Parent R01 Clinical Trial Not Allowed) |
|
Hawkins, Shannon Michelle |
Indiana Univ-Purdue Univ At Indianapolis
United States |
Targeting cellular senescence to inhibit the development and progression of ovarian endometriomas |
5R01HD109707-02 |
PA-20-185 (Parent R01 Clinical Trial Not Allowed) |
|
Valdimarsdottir, Heiddis |
Icahn School Of Medicine At Mount Sinai
United States |
Systematic Light Exposure Effects on Circadian Rhythms Entrainment, Inflammation, Neutropenic Fever and Symptom Burden among Multiple Myeloma Patients undergoing Autologous Stem Cell Transplantation |
5R01CA260961-02 |
PAR-21-035 (R01 Clinical Trial Required) |
|
El-Serag, Hashem B |
Baylor College Of Medicine
United States |
Prevention of Hepatocellular Carcinoma Related to Metabolic Syndrome |
5P01CA263025-02 |
|
|
Sidransky, David |
Johns Hopkins University
United States |
Racial differences in Immunogenetic Tumorigenesis of Head and Neck Squamous Cell Carcinoma |
5R01CA265975-02 |
|
|
Ross, Stephen |
New York University School Of Medicine
United States |
Psilocybin Therapy for Advanced Cancer-related Psychiatric Distress |
5R01CA268521-02 |
|
Rachel Altshuler, Ph.D. |
Salvemini, Daniela |
Saint Louis University
United States |
Fingolimod and Ozanimod for the treatment and prevention of chemobrain |
5R01CA261979-02 |
|
Rachel Altshuler, Ph.D. |
Feng, Ziding |
Fred Hutchinson Cancer Center
United States |
The Early Detection Research Network: Data Management and Coordinating Center |
5U24CA086368-23 |
RFA-CA-21-034 (U24 Clinical Trial Not Allowed) |
|
Vilar-Sanchez, Eduardo |
University Of Tx Md Anderson Can Ctr
United States |
Cancer Immune-Interception in a Spontaneous Non-Human Primate Model of Lynch Syndrome |
5R01CA260761-02 |
PA-20-185 (Parent R01 Clinical Trial Not Allowed) |
|
Sohl, Stephanie Jean |
Wake Forest University Health Sciences
United States |
REmotely-delivered Supportive Programs for Improving surgical pain and disTrEss (RESPITE) |
5R01CA266995-02 |
PAR-21-035 (R01 Clinical Trial Required) |
Goli Samimi, Ph.D., M.P.H. |
Murphy, Elizabeth Angela |
University Of South Carolina At Columbia
United States |
A Transdisciplinary Approach to Investigating Metabolic Dysregulation in Obese Parent and Child Dyads and Risk of Colorectal Cancer - admin supplement |
3U01CA272977-02S1 |
|
|
Zhang, Zhen |
Johns Hopkins University
United States |
A multidisciplinary BCC for ovarian cancer early detection: translating discoveries to clinical use with a by-design approach |
5U2CCA271891-02 |
|
Christos Patriotis, Ph.D., M.Sc. |
Grady, William Mallory |
Fred Hutchinson Cancer Center
United States |
Biomarkers for optimizing risk prediction and early detection of cancers of the colon and esophagus |
5U2CCA271902-02 |
|
Matthew Young, Ph.D. |
Lenburg, Marc Elliott |
Boston University Medical Campus
United States |
The Boston University - UCLA Lung Cancer Biomarker Characterization Center |
5U2CCA271898-02 |
|
|
Sun, Ju |
University Of Minnesota
United States |
SCH: A New Computational Framework for Learning from Imbalanced Biomedical Data |
1R01CA287413-01 |
|
Amanda Skarlupka, Ph.D. |
Goode, Diana J |
University Of New England
United States |
Novel expression of MHC class II on DRG neurons and its role in promoting antinociceptive CD4+ T cells in females during chemotherapy-induced peripheral neuropathy |
5R01CA267554-02 |
|
Rachel Altshuler, Ph.D. |
Singal, Amit |
Ut Southwestern Medical Center
United States |
Clinical Validation Center for Hepatocellular Carcinoma |
5U01CA271887-02 |
|
|
Chinnaiyan, Arul M |
University Of Michigan At Ann Arbor
United States |
Michigan-VUMC Biomarker Characterization Center |
5U2CCA271854-02 |
|
|
Li, Christopher I |
Fred Hutchinson Cancer Center
United States |
Fred Hutchinson Breast Cancer Clinical Validation Center |
5U01CA152637-13 |
|
|
Majumder, Shounak |
Mayo Clinic Rochester
United States |
Mayo Clinic Prospective Resource for Biomarker Validation and Early Detection of Pancreatic Cancer |
5U01CA210138-07 |
PAR-21-334 (U01 Clinical Trial Optional) |
|
Webster, Nicholas J |
University Of California, San Diego
United States |
Time-restricted feeding and breast cancer |
5R01CA196853-07 |
PA-20-185 (Parent R01 Clinical Trial Not Allowed) |
|
Infante, Rodney E |
Ut Southwestern Medical Center
United States |
Identifying the Cellular and Molecular Targets of JAK/STAT-Driven Adipose Wasting to Reverse Cancer Cachexia |
5R01CA266900-02 |
PA-20-185 (Parent R01 Clinical Trial Not Allowed) |
|
Markowitz, Sanford D. |
Case Western Reserve University
United States |
Validation of Biomarkers for predicting Barrett's esophagus that will or will not: i) progress towards cancer, or ii) recur after ablation |
5U01CA271867-02 |
RFA-CA-21-033 (U01 Clinical Trial Optional) |
|
Wolpin, Brian Matthew |
Dana-Farber Cancer Inst
United States |
Altered metabolism and machine learning for pancreatic cancer early detection |
5U01CA210171-07 |
PAR-21-334 (U01 Clinical Trial Optional) |
|
Lin, Jia-Ren |
Harvard Medical School
United States |
Advancing technologies for the collection and analysis of high dimensional immunoprofiles and tumor images |
5R50CA274277-02 |
|
|
Oberg, Ann Laura |
Mayo Clinic Rochester
United States |
Management and Data Coordination Unit for PCDC |
5U24CA274496-02 |
PAR-21-335 (U24 Clinical Trial Not Allowed) |
|
Cheng, Leo L |
Massachusetts General Hospital
United States |
Novel metabolomic contrast probes for human lung cancer characterization |
5R01CA273010-02 |
PA-20-185 (Parent R01 Clinical Trial Not Allowed) |
|
Hanash, Samir M |
University Of Tx Md Anderson Can Ctr
United States |
Clinical Validation Center for Lung Cancer Early Detection |
5U01CA271888-02 |
RFA-CA-21-033 (U01 Clinical Trial Optional) |
|
Schoen, Robert E. |
University Of Pittsburgh At Pittsburgh
United States |
Blood-Based Testing for Advanced Adenoma |
5U01CA271884-02 |
RFA-CA-21-033 (U01 Clinical Trial Optional) |
|
Robbins, Hilary A. |
International Agency For Res On Cancer
United States |
The Lung EArly Proteins project: A LEAP toward implementing biomarkers in lung cancer screening |
5R01CA262164-02 |
PA-20-185 (Parent R01 Clinical Trial Not Allowed) |
|
Ghobrial, Irene M. |
Dana-Farber Cancer Inst
United States |
Molecular prediction of myeloma in African Americans |
5U01CA271492-02 |
PAR-18-913 (U01 Clinical Trial Not Allowed) |
|
Yeh, Jennifer M. |
Boston Children'S Hospital
United States |
Can risk-reducing medications improve breast cancer prevention in childhood and adolescent cancer survivors? Comparative modeling to inform care |
5R01CA261874-02 |
|
Eileen Dimond, R.N., M.S. |
Zhao, Hua |
University Of Virginia
United States |
Homologous recombination repair capacity in peripheral blood lymphocytes as a breast cancer risk factor |
7U01CA260731-02 |
PAR-18-913 (U01 Clinical Trial Not Allowed) |
|
Balu, Mihaela |
University Of California-Irvine
United States |
Fast, large area, multiphoton exoscope (FLAME) for improving early detection of melanoma |
5R01CA259019-02 |
PAR-20-155 (R01 Clinical Trial Optional) |
|
Chung, Raymond T |
Massachusetts General Hospital
United States |
Trial of Statins for Chemoprevention in Hepatocellular Carcinoma |
5R01CA255621-03 |
|
|
Grogan, Eric L |
Vanderbilt University Medical Center
United States |
Clinical Utility of a Combined Biomarker Approach to Diagnose Lung Cancer |
5U01CA152662-12 |
RFA-CA-21-033 (U01 Clinical Trial Optional) |
|
Chan, Andrew T |
Massachusetts General Hospital
United States |
Precision Prevention Research Program |
5R35CA253185-04 |
PAR-19-349 (R35 Clinical Trial Not Allowed) |
|
Carlsson, Sigrid |
Sloan-Kettering Inst Can Research
United States |
Influence of intra-individual variability in serial screening samples on clinical decision-making for risk stratification and biopsy by a single PSA and additional markers |
5U01CA266535-02 |
PAR-18-913 (U01 Clinical Trial Not Allowed) |
|
Grimm, Lars J |
Duke University
United States |
Dynamic imaging and tissue biomarker models to delineate indolent from aggressive breast calcifications |
5R01CA271237-02 |
PAR-19-264 (R01 Clinical Trial Optional) |
|
Yuan, Ying |
University Of Tx Md Anderson Can Ctr
United States |
Coordinating and Data Management Center for Translational and Basic Science Research in Early Lesions |
5U24CA274212-02 |
RFA-CA-21-055 (U24 Clinical Trial Not Allowed) |
|
Goggins, Michael G. |
Johns Hopkins University
United States |
Using markers to improve pancreatic cancer screening and surveillance: a multi-center study |
5U01CA210170-07 |
PAR-21-334 (U01 Clinical Trial Optional) |
|
Hollingsworth, Michael A. |
University Of Nebraska Medical Center
United States |
Pancreatic Cancer Detection Consortium |
5U01CA210240-07 |
PAR-21-334 (U01 Clinical Trial Optional) |
|
Zhou, Xianghong Jasmine |
University Of California Los Angeles
United States |
Detecting and locating cancer for patients with CT-detected lung nodules |
5R01CA264864-02 |
PAR-19-264 (R01 Clinical Trial Optional) |
|
Rosenbluth, Jennifer M |
University Of California, San Francisco
United States |
In vitro models as a window to learn how to change outcomes in women at high risk of developing breast cancer |
5R01CA281361-02 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
Clapper, Margie L. |
Research Inst Of Fox Chase Can Ctr
United States |
Cancer Prevention-Interception Targeted Agent Discovery Program at Fox Chase Cancer Center |
5U54CA272686-02 |
RFA-CA-21-038 (U54 Clinical Trial Not Allowed) |
|
Lipkin, Steven M |
Weill Medical Coll Of Cornell Univ
United States |
CAP-IT Center for LNP RNA Immunoprevention |
5U54CA272688-02 |
RFA-CA-21-038 (U54 Clinical Trial Not Allowed) |
|
Wu, Yun |
State University Of New York At Buffalo
United States |
Lung Cancer Early Detection and Immunotherapy Response Prediction and Monitoring with an Exo-PROS Liquid Biopsy Assay |
5R01CA272827-02 |
PA-20-185 (Parent R01 Clinical Trial Not Allowed) |
|
Plas, Ellen Van Der |
Arkansas Children'S Hospital Res Inst
United States |
Identifying markers of abnormal neurocognitive trajectories during chemotherapy treatment of childhood acute lymphoblastic leukemia |
5R37CA266135-02 |
PA-20-185 (Parent R01 Clinical Trial Not Allowed) |
|
Lu, Junxuan |
Pennsylvania State Univ Hershey Med Ctr
United States |
Early clinial trials for Angelica herbal supplements for prostate cancer interception |
5R01CA260901-02 |
PAR-21-035 (R01 Clinical Trial Required) |
|
Maitra, Anirban |
University Of Tx Md Anderson Can Ctr
United States |
Clinical Validation Center for Early Detection of Pancreatic Cancer |
5U01CA200468-07 |
|
|
Grady, William Mallory |
Fred Hutchinson Cancer Center
United States |
High-resolution mutational landscape of the primed colon in early onset colorectal cancer |
3U54CA274374-02S1 |
|
|
Hoshida, Yujin |
Ut Southwestern Medical Center
United States |
Therapeutic modulation of a proteomic HCC risk signature with statins in patients with liver cirrhosis |
1U01CA288375-01 |
|
|
Herman, James G. |
University Of Pittsburgh At Pittsburgh
United States |
Optimizing Ultrasensitive DNA methylation detection for lung cancer and other malignancies |
5U2CCA271885-02 |
|
Wendy Wang, Ph.D., M.Sc. |
Labaer, Joshua |
Arizona State University-Tempe Campus
United States |
High-throughput immunoproteomics for cancer biomarker discovery |
5U2CCA271903-02 |
|
Christos Patriotis, Ph.D., M.Sc. |
Skates, Steven J |
Massachusetts General Hospital
United States |
Genome-wide methylation and proteomic analysis of uterine lavage and cervical swab for early detection of ovarian cancer |
5U2CCA271871-02 |
|
Christos Patriotis, Ph.D., M.Sc. |
Slager, Susan L |
Mayo Clinic Rochester
United States |
The genetic and epigenetic etiology of progression from the precursor state to chronic lymphocytic leukemia (CLL) |
5R01CA258465-02 |
|
|
Cheville, Andrea Lynne |
Mayo Clinic Rochester
United States |
Achieving Equity through SocioCulturally-informed, Digitally-Enabled Cancer Pain managemeNT” (ASCENT) Clinical Trial |
4R33CA278594-02 |
|
Brennan Streck, Ph.D., R.N., M.P.H. |
Im, Eun-Ok |
University Of Texas At Austin
United States |
Cancer Pain Management: A Technology-Based Intervention for Asian American Breast Cancer Survivors |
4R33CA280979-02 |
|
Brennan Streck, Ph.D., R.N., M.P.H. |
Rotemberg, Veronica Miriam |
Sloan-Kettering Inst Can Research
United States |
M-ISIC: A Multimodal Open-Source International Skin Imaging Collaboration Informatics Platform for Automated Skin Cancer Detection |
5U24CA264369-02 |
|
Guillermo Marquez, Ph.D. |
Li, Yong |
Baylor College Of Medicine
United States |
Cancer Prevention-Interception Against MGUS Progression |
1U54CA272691-01A1 |
|
Vignesh Gunasekharan, Ph.D. |
Semmes, Oliver John |
Eastern Virginia Medical School
United States |
Virginia-UCLA-Toronto Biomarker Characterization Center |
5U2CCA271894-02 |
|
Indu Kohaar, Ph.D. |
Cocucci, Emanuele |
Ohio State University
United States |
A SYNTHETIC BIOMARKER TO UNIVERSALLY ASSESS THE RELATIVE CONTRIBUTION OF HEATHY AND CANCEROUS TISSUE TO CIRCULATING EV POOL |
5R01CA270251-02 |
PAR-20-053 (R01 Clinical Trial Not Allowed) |
|
Stachler, Matthew D |
University Of California, San Francisco
United States |
Optimization and validation of a biomarker panel for risk stratification in Barrett's esophagus |
5R37CA269649-02 |
PA-20-185 (Parent R01 Clinical Trial Not Allowed) |
|
Huang, Ying |
Fred Hutchinson Cancer Center
United States |
Accelerating biomarker development through novel statistical methods for analyzing phase III/IV studies |
5R01CA277133-02 |
|
Nick Hodges, Ph.D. |
Lee, Juhun |
University Of Pittsburgh At Pittsburgh
United States |
Detecting Mammographically-Occult Cancer in Women with Dense Breasts Using Digital Breast Tomosynthesis |
5R01CA269540-02 |
|
|
Pyter, Leah M |
Ohio State University
United States |
Chemotherapy-induced circadian master clock disruptions and fatigue |
3R01CA270372-02S1 |
PA-20-185 (Parent R01 Clinical Trial Not Allowed) |
|
Staff, Nathan P |
Mayo Clinic Rochester
United States |
Investigating the role of MAP2 in chemotherapy-induced peripheral neurotoxicity |
5R01CA275870-02 |
|
Rachel Altshuler, Ph.D. |
Mehrara, Babak J |
Sloan-Kettering Inst Can Research
United States |
Mechanisms of racial disparity in breast cancer-related lymphedema |
5R01CA278599-02 |
|
|
Anderson, Garnet L. |
Fred Hutchinson Cancer Center
United States |
NCI Cancer Screening Research Network: Coordinating and Communication Center |
1UG1CA286954-01 |
|
Elyse LeeVan, M.D., M.P.H. |
Kooperberg, Charles L |
Fred Hutchinson Cancer Center
United States |
Statistics and Data Management Center (SDMC) for the NCI Cancer Screening Research Network (CSRN) |
1UG1CA287013-01 |
|
Elyse LeeVan, M.D., M.P.H. |
Doescher, Mark P |
University Of Oklahoma Hlth Sciences Ctr
United States |
Oklahoma Tribal, Rural, Urban Cancer Screening Trial ACCESS Hub |
1UG1CA287044-01 |
|
Elyse LeeVan, M.D., M.P.H. |
Krist, Alexander H |
Virginia Commonwealth University
United States |
Virginia Cancer Screening Research Network Access Hub (Virginia CSRN Hub) |
1UG1CA287017-01 |
|
Elyse LeeVan, M.D., M.P.H. |
Lee, Jeffrey Kuang Zou |
Kaiser Foundation Research Institute
United States |
Multi-Ethnic Multi-Cancer Early Detection and Screening (MED SCREEN) Study |
1UG1CA287011-01 |
|
Elyse LeeVan, M.D., M.P.H. |
Neslund-Dudas, Christine Marie |
Henry Ford Health + Michigan State University Health Sciences
United States |
HFH-MSU CSRN ACCrual Enrollment and Screening Site |
1UG1CA287007-01 |
|
Elyse LeeVan, M.D., M.P.H. |
Reuland, Daniel S. |
Univ Of North Carolina Chapel Hill
United States |
Cancer Screening Research Network - North Carolina Hub (CSRN-NC HUB) |
1UG1CA286949-01 |
|
Elyse LeeVan, M.D., M.P.H. |
James, Aimee S |
Washington University
United States |
Building equity in cancer screening through research: The Siteman Catchment CSRN Hub |
1UG1CA286946-01 |
|
Elyse LeeVan, M.D., M.P.H. |
Cook, Linda S |
University Of Colorado Denver
United States |
Improving Strategies for Cancer Reduction through Early-detection and ENgagement (I-SCREEN) |
1UG1CA286941-01 |
|
Elyse LeeVan, M.D., M.P.H. |
Giles, Erin |
University Of Michigan At Ann Arbor
United States |
Obesity, body fat distribution, and breast cancer risk: is visceral fat the culprit after menopause? |
5R01CA269726-02 |
PA-20-185 (Parent R01 Clinical Trial Not Allowed) |
|
Yu, Dihua |
University Of Tx Md Anderson Can Ctr
United States |
Exploring novel strategies for immunoprevention of estrogen receptor negative breast cancer |
5R01CA270010-02 |
PA-20-185 (Parent R01 Clinical Trial Not Allowed) |
|
Ah, Diane Marie Von |
Ohio State University
United States |
Cognitive Training for Cancer-related Cognitive Impairment: A Multi-Center Randomized Controlled Trial |
5R01CA276222-02 |
|
|
Atigadda, Venkatram Reddy |
University Of Alabama At Birmingham
United States |
Development of Potent and non-toxic rexinoids to prevent non-melanoma skin cancer |
5R01CA276683-02 |
|
|
Rosser, Charles J |
Cedars-Sinai Medical Center
United States |
A Multiplex Protein Biomarker-Based Immunoassay for the Early Detection of Bladder Cancer and its Implications in Tumor Biology |
5R01CA277810-02 |
|
|
Acharya, Munjal M |
University Of California-Irvine
United States |
Stem cell-derived exosomes to ameliorate chemobrain |
5R01CA262213-02 |
|
Rachel Altshuler, Ph.D. |
Brand, Randall |
University Of Pittsburgh At Pittsburgh
United States |
Validation of biomarkers for risk prediction and early diagnosis of Pancreatic Adenocarcinoma |
5U01CA200466-07 |
|
|
Kibel, Adam S |
Brigham And Women'S Hospital
United States |
Polygenic risk stratification combined with mpMRI to identify clinically relevant prostate cancer |
1U01CA268810-01A1 |
|
Richard Mazurchuk, Ph.D. |
Dashwood, Roderick H |
Texas A&M University Health Science Ctr
United States |
Immunoepigenetic targeting of MHC regulators in FAP |
5R01CA257559-02 |
|
|
Boutros, Paul Christopher |
University Of California Los Angeles
United States |
Germline Determinants of Prostate Cancer Evolution |
5R01CA270108-02 |
|
|
Diaz, Juan Sebastian Gomez |
University Of California At Davis
United States |
A miniaturized neural network enabled nanoplasmonic spectroscopy platform for label-free cancer detection in biofluids |
5R01CA273253-02 |
|
|
Brown, Austin L |
Baylor College Of Medicine
United States |
A Systems Epidemiology Approach for Predicting Methotrexate Neurotoxicity in Pediatric Acute Leukemia |
5R01CA272981-02 |
|
|
Damaj, M. Imad |
Virginia Commonwealth University
United States |
Targeting Sphingosine-1-phosphate (S1P1) receptors for the treatment of Aromatase Inhibitors-induced Musculoskeletal Symptoms |
5R01CA272147-02 |
|
|
Cohen, Lorenzo |
University Of Tx Md Anderson Can Ctr
United States |
Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer Surgery |
1R01CA272565-01A1 |
|
|
Sears, Rosalie C |
Oregon Health & Science University
United States |
Validation of novel imaging and molecular tests for early detection of pancreatic cancer through risk-stratified community engagement programs |
1U01CA278923-01 |
|
Matthew Young, Ph.D. |
Segal, Leopoldo Nicolas |
New York University School Of Medicine
United States |
Microbial and host biomarker development for detection and prognosis of early stage non-small cell lung cancer |
1U2CCA271890-01A1 |
|
Guillermo Marquez, Ph.D. |
Moscicki, Anna-Barbara |
University Of California Los Angeles
United States |
Real-world effectiveness of HPV vaccine in women living with HIV and its impact on cervical cancer screening accuracies |
1R01CA281293-01 |
|
Silvina Frech, Ph.D., M.S. |
Bast, Robert C |
University Of Tx Md Anderson Can Ctr
United States |
MD Anderson Cancer Center EDRN- Clinical Validation Center for Early Detection of Ovarian Cancer with a multiple marker algorithm |
2U01CA200462-06A1 |
|
|
Yu, Anthony Francis |
Sloan-Kettering Inst Can Research
United States |
Intensive Blood Pressure Control During Cardiotoxic Breast Cancer Treatment (PROTECT) Trial |
1R37CA273923-01A1 |
|
Eileen Dimond, R.N., M.S. |
Sukumar, Saraswati |
Johns Hopkins University
United States |
Development of an automated, point of care DNA methylation cartridge blood test for colorectal cancer detection in LMICs- an academic-industrial partnership |
1R01CA278816-01 |
|
Matthew Young, Ph.D. |
Shah, Sohrab |
Sloan-Kettering Inst Can Research
United States |
Exploiting markers of genomic instability in high-risk pre-invasive ovarian cancer |
1R01CA281928-01 |
|
Christos Patriotis, Ph.D., M.Sc. |
Paulovich, Amanda G |
Fred Hutchinson Cancer Center
United States |
Breast-cancer focused biomarker characterization center employing targeted mass spec assays in a CLIA environment |
1U2CCA271873-01A1 |
|
Sidney Fu, M.D. |
Buczynski, Matthew Wallace |
Virginia Polytechnic Inst And St Univ
United States |
Anti-nociceptive actions of CART II in chemotherapy-induced peripheral neuropathy |
1R01CA284075-01 |
|
Rachel Altshuler, Ph.D. |
Allen, Peter J |
Duke University
United States |
Biomarker validation for intraductal papillary mucinous neoplasms of the pancreas |
2R01CA182076-06A1 |
|
|
Sanda, Martin G |
Emory University
United States |
Prostate Cancer Biomarker and Imaging Validation Alliance: Emory University, University of Alabama Birmingham, and University of Texas Southwestern |
2U01CA113913-16A1 |
|
|
Thangaraju, Muthusamy |
Augusta University
United States |
Bacteria-derived xenobiotics in colon cancer prevention: Link to GPR109A and colonic ketogenesis |
1R01CA275840-01A1 |
|
Winfred Malone, Ph.D., M.P.H. |
Hilakivi-Clarke, Leena A. |
University Of Minnesota
United States |
Effect of maternal obesity on breast cancer among offspring: role of the gut microbiota |
1R01CA276775-01A1 |
|
Amit Kumar, Ph.D. |
Velculescu, Victor E. |
Johns Hopkins University
United States |
DNA evaluation of fragments for early interception (DELFI) of Lung cancer |
1U01CA271896-01A1 |
|
|
Chan, Daniel Wanyui |
Johns Hopkins University
United States |
Development of a panel of multiplex biomarkers for the early detection of pancreatic ductal adenocarcinoma and high-risk lesions |
1U01CA274514-01A1 |
|
|
Zhu, Yazhen |
University Of California Los Angeles
United States |
Click Chemistry-Mediated Surface Protein Assay for Quantifying Subpopulations of Hepatocellular Carcinoma-associated Extracellular Vesicles |
1R01CA277530-01A1 |
|
|
Bhatt, Vijaya Raj |
University Of Nebraska Medical Center
United States |
Aging trajectories and outcomes of older adults with acute myeloid leukemia |
1R37CA276928-01A1 |
|
Brennan Streck, Ph.D., R.N., M.P.H. |
Yaghjyan, Lusine |
University Of Florida
United States |
Stromal contributions to breast carcinogenesis |
1R01CA277817-01A1 |
|
Christos Patriotis, Ph.D., M.Sc. |
Castro, Cesar M |
Massachusetts General Hospital
United States |
Composing CODAs to cervical cancer screening through an integrated CRISPR and fluorescent nucleic acid approach |
1U01CA279858-01 |
|
Christos Patriotis, Ph.D., M.Sc. |
Punnen, Sanoj |
University Of Miami School Of Medicine
United States |
The Rigor and Clinical Utility of PSMA Enriched Extracellular Vesicles for Prostate Cancer Detection |
1R01CA272766-01A1 |
|
Matthew Young, Ph.D. |
Freedland, Stephen Jay |
Cedars-Sinai Medical Center
United States |
Intermittent Fasting using a Fasting-Mimetic Diet to Improve Prostate Cancer Control and Metabolic Outcomes |
1R01CA280081-01 |
|
Sharon Ross, Ph.D., M.P.H. |
Chan, Daniel Wanyui |
Johns Hopkins University
United States |
BCC for Prostate Cancer: Discovery and Translation of Biomarkers for Clinical Unmet Needs |
1U2CCA271895-01A1 |
|
Indu Kohaar, Ph.D. |
Hu, Shuiying |
Ohio State University
United States |
Targeting neuronal transport to ameliorate vincristine neurotoxicity |
1R01CA272254-01A1 |
|
Rachel Altshuler, Ph.D. |
Mclouth, Laurie |
University Of Kentucky
United States |
Pathways, a Hope-Based Intervention to Support Personal Goal Pursuit, Mental Health, and Quality of Life during Advanced Lung Cancer Treatment |
1R01CA283929-01 |
|
Brennan Streck, Ph.D., R.N., M.P.H. |
Goel, Ajay |
Beckman Research Institute/City Of Hope
United States |
Exosome-based microRNA biomarkers for Non-invasive and Early Detection of Pancreatic Cancer |
2U01CA214254-06 |
|
|
Pinder, Leeya F |
University Of Cincinnati
United States |
RepurPosed AntiretrOviraL ThErapieS to EliminAte Cervical Cancer (POLESA Trial) |
1R37CA284033-01 |
|
Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H. |
Lampe, Paul D |
Fred Hutchinson Cancer Center
United States |
Autoantibodies to tumor-derived neoepitopes as biomarkers and immunoPET agents for the early detection of small cell lung cancer |
1R01CA281801-01 |
|
Richard Mazurchuk, Ph.D. |
Morilak, David A |
University Of Texas Hlth Science Center
United States |
Therapy-induced cognitive impairment in a rat model of prostate cancer |
1R01CA285183-01 |
|
Catherine Schweppe, Ph.D. |
Bryan, Angela |
University Of Colorado
United States |
Cannabis for Palliative Care in Cancer: A Placebo-controlled Randomized Trial of Full Spectrum Hemp-derived CBD/THC |
1R01CA284860-01 |
|
Brennan Streck, Ph.D., R.N., M.P.H. |
Nyamathi, Adeline M |
University Of California-Irvine
United States |
Secondary Cervical Cancer Prevention of Vulnerable Women with HPV and HIV Co-infection in India |
1R01CA285063-01 |
|
Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H. |
Salami, Simpa Samuel |
University Of Michigan At Ann Arbor
United States |
Defining the Biological Arc of Grade Group 1 Prostate Cancer |
1R37CA283857-01 |
|
Guillermo Marquez, Ph.D. |
Anderson, Karen S. |
Arizona State University-Tempe Campus
United States |
Southwest EDRN Clinical Validation Center for Head and Neck Cancer |
1U01CA281660-01 |
|
Wendy Wang, Ph.D., M.Sc. |
Lindau, Stacy Tessler |
University Of Chicago
United States |
Bionic Breast Project: A Neuroprosthesis to Restore Touch Sensation and Reduce Chronic Pain After Mastectomy |
1R01CA281301-01A1 |
|
Marjorie Perloff, M.D. |
Schroeck, Florian R |
Veterans Education/Res/Assn/North/Ne
United States |
Replacing Invasive Cystoscopy with Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance |
1R37CA275916-01 |
|
Claire Zhu, Ph.D. |
Goel, Ajay |
Beckman Research Institute/City Of Hope
United States |
Exosomal biomarkers for the early detection of hepatocellular carcinoma |
1R01CA271443-01A1 |
|
Matthew Young, Ph.D. |
Olopade, Olufunmilayo F. |
University Of Chicago
United States |
Chicago Alternative Prevention Study for BReast CAncer in Diverse Populations of High-Risk Women (CAPSBRACA) |
1R01CA276652-01A1 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
Basu, Partha |
International Agency For Res On Cancer
United States |
A novel, one stop, affordable, point of care and artificial intelligence supported system of screening, triage and treatment selection for cervical cancer and precancer in the LMICs |
1R37CA275824-01 |
|
Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H. |
Afshar-Kharghan, Vahid |
University Of Tx Md Anderson Can Ctr
United States |
Novel Biomarkers Predicting Blood Clots in Ovarian Cancer |
1R01CA275762-01A1 |
|
Rachel Altshuler, Ph.D. |
Zhou, Xianghong Jasmine |
University Of California Los Angeles
United States |
The UCLA Center in Early Detection of Liver Cancer |
2U01CA230705-06 |
|
|
Lyden, David Charles |
Weill Medical Coll Of Cornell Univ
United States |
Application of 4D proteomics and super-resolution microscopy in extracellular vesicle and particle-borne biomarker discovery for early pancreatic cancer detection |
2R01CA218513-06A1 |
PAR-16-276 (R01) |
|
Kanwal, Fasiha |
Baylor College Of Medicine
United States |
Risk Stratification for and Early Detection of Liver Cancer |
2U01CA230997-06 |
|
|
Heine, John J |
H. Lee Moffitt Cancer Ctr & Res Inst
United States |
Quantitative Imaging Clinical Validation Center at Moffitt Cancer Center |
2U01CA200464-06A1 |
|
|
Iwelunmor, Juliet |
Saint Louis University
United States |
Innovative Rapid Enabling, Affordable, point-of-Care HPV Self-Testing Strategy (I-REACH) |
1U01CA279863-01 |
|
|
Hill, Joshua Aiden |
Fred Hutchinson Cancer Center
United States |
Immunoglobulin Replacement Therapy and Infectious Complications After CD19-Targeted CAR-T-Cell Therapy |
1R01CA276040-01A1 |
|
Sharon Ross, Ph.D., M.P.H. |
Sedrak, Mina S |
University Of California Los Angeles
United States |
Targeting Senescence to Mitigate Chemotherapy-induced Functional Decline |
1R01CA280088-01 |
|
Goli Samimi, Ph.D., M.P.H. |
Fiol, Guilherme Del |
University Of Utah
United States |
GARDE: Scalable Clinical Decision Support for Individualized Cancer Risk Management |
1U24CA274582-01A1 |
|
Christos Patriotis, Ph.D., M.Sc. |
Hoshida, Yujin |
Ut Southwestern Medical Center
United States |
Epigallocatechin gallate for prevention of lethal cirrhosis complications |
1R01CA282178-01 |
|
Asad Umar, D.V.M., Ph.D. |
Alexandrov, Ludmil B |
University Of California, San Diego
United States |
Mapping immuno-genomic drivers of the head and neck precancer invasive-disease transition |
1U01CA290479-01 |
|
Wendy Wang, Ph.D., M.Sc. |
Simeone, Diane M |
New York University School Of Medicine
United States |
Biomarker Validation in Pancreatic Cystic Neoplasms |
1U01CA282272-01 |
|
|
Ji, Hanlee P |
Stanford University
United States |
Precision Interception of Gastric Cancer Precursors Through Molecular and Cellular Risk Stratification |
1P01CA265772-01A1 |
|
Asad Umar, D.V.M., Ph.D. |
Zheng, Yingye |
Fred Hutchinson Cancer Center
United States |
Precompetitive Collaboration on Liquid Biopsy for Early Cancer Assessment: Data Management and Coordinating Unit |
1U24CA288185-01 |
|
Christos Patriotis, Ph.D., M.Sc. |
Ghosh, Jayashri |
Temple Univ Of The Commonwealth
United States |
Development of blood-based methylation biomarkers for CRC risk prediction |
1R01CA281948-01 |
|
Matthew Young, Ph.D. |
Flowers, Lisa C. |
Emory University
United States |
Screening strategies and social determinants of health among people with high risk of anal cancer |
1R01CA285198-01 |
|
Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H. |
Fahrmann, Johannes F |
University Of Tx Md Anderson Can Ctr
United States |
Blood-Based Biomarkers for Personalized Risk Assessment of Breast and Ovarian Cancer |
1U01CA282216-01 |
|
Claire Zhu, Ph.D. |
Zhou, Xianghong Jasmine |
University Of California Los Angeles
United States |
Multi-cancer early detection using cell-free DNA methylome analysis |
1U01CA285010-01 |
|
|
Chak, Amitabh |
Case Western Reserve University
United States |
Pathways of Injury and Repair in Barrett's Carcinogenesis |
1P01CA269019-01A1 |
|
Ellen Richmond, M.S., G.N.P.-B.C. |
Singal, Amit |
Ut Southwestern Medical Center
United States |
Precision Risk Stratification and Screening for HCC among Patients with Indeterminate Liver Nodules |
1U01CA283935-01 |
|
Matthew Young, Ph.D. |
Villanueva, Augusto |
Icahn School Of Medicine At Mount Sinai
United States |
Liquid biopsy and radiomics for liver cancer surveillance |
1U01CA283931-01 |
|
Matthew Young, Ph.D. |
Curtius, Kathleen M. |
University Of California, San Diego
United States |
Multiscale modeling of spatiotemporal evolution in Barrett's esophagus |
1R01CA270235-01A1 |
|
Ellen Richmond, M.S., G.N.P.-B.C. |
Kim, Hyung L |
Cedars-Sinai Medical Center
United States |
Intensive cholesterol-lowering intervention and anti-tumor immunity modeled in prostate cancer |
1R01CA280060-01A1 |
|
Howard L. Parnes, M.D. |
Gudas, Lorraine J |
Weill Medical Coll Of Cornell Univ
United States |
CD 1530, an RAR Gamma Agonist for Oral Cavity Squamous Cell Carcinoma Prevention |
1R01CA270248-01A1 |
|
Winfred Malone, Ph.D., M.P.H. |
Feng, Ziding |
Fred Hutchinson Cancer Center
United States |
Consortium on Translational Research in Early Detection of Liver Cancer:Data Management and Coordinating Center (DMCC) |
2U24CA230144-07 |
|
Guillermo Marquez, Ph.D. |
Yu, Danxia |
Vanderbilt University Medical Center
United States |
Gut microbiota-related mechanisms that impact colorectal cancer risk after bariatric surgery |
1R01CA275864-01A1 |
|
Edward Sauter, M.D., Ph.D. |
Chan, Alexandre |
University Of California-Irvine
United States |
Neurotrophic strategy to mitigate chemotherapy-related brain injury |
1R01CA276212-01A1 |
|
Catherine Schweppe, Ph.D. |
Bergan, Raymond C |
University Of Nebraska Medical Center
United States |
Preventing invasive prostate cancer |
1R01CA276846-01 |
|
John Clifford, Ph.D. |
Sands, Stephen Alan |
Sloan-Kettering Inst Can Research
United States |
Prospective international phase-III study to improve neurocognitive outcomes in young children with low-risk medulloblastoma (YCMB-LR) |
1R01CA283045-01 |
|
Catherine Schweppe, Ph.D. |
Kuhn, Peter |
University Of Southern California
United States |
Multi-modal Liquid Biopsy Early Assessment of Breast Cancer, Pancreatic Cancer, and Multiple Myeloma |
1U01CA285013-01 |
|
|
Lee, Hakho |
Massachusetts General Hospital
United States |
Expanding early cancer detection with high throughput OCEANA - Ovarian Cancer Exosome Analysis with Nanoplasmonic Array |
1U01CA284982-01 |
|
|
Arnold, Corey Wells |
University Of California Los Angeles
United States |
Computational Feature Profiling and Modeling for Prostate Cancer Detection and Risk Stratification |
1R01CA279666-01A1 |
|
Indu Kohaar, Ph.D. |
Panigrahy, Dipak |
Beth Israel Deaconess Medical Center
United States |
Control of cancer cachexia via stimulation of resolution of inflammation |
1R01CA276107-01A1 |
|
|
Garcia, Jose M. |
Seattle Inst For Biomedical/Clinical Res
United States |
SArcopenia in Men with Prostate Cancer undergoing ADT (SAP-ADT) |
1R01CA279220-01A1 |
|
|
You, Ming |
Methodist Hospital Research Institute
United States |
Targeting phenethyl isothiocyanate to mitochondria in lung carcinogenesis |
1R01CA280746-01A1 |
|
John Clifford, Ph.D. |
Mcguire, Andrew |
Fred Hutchinson Cancer Center
United States |
Rational Vaccine Design to prevent HIV-Associated Lymphoma |
1R01CA285227-01A1 |
|
Winfred Malone, Ph.D., M.P.H. |
Jacob, Jennifer B |
Wayne State University
United States |
Defining Cancer Intervention Targets by Functional Genomics Analysis of Outbred F1 Mice |
1R01CA278818-01A1 |
|
Vignesh Gunasekharan, Ph.D. |
Torres, Keila Enitt |
University Of Tx Md Anderson Can Ctr
United States |
Use of Noninvasive Biomarkers and Advanced MRI for early detection of NF1-associated MPNSTs |
1R01CA285980-01 |
|
Richard Mazurchuk, Ph.D. |
Huh, Warner King |
University Of Alabama At Birmingham
United States |
Misoprostol to Optimize Prevention of Cancer of the Cervix: A Randomized Trial (MISOPCx Project) |
1R01CA279021-01A1 |
|
Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H. |
Badve, Sunil S. |
Emory University
United States |
Early prediction of lethal phenotypes in triple negative breast cancer using multiscale, multi-modality platforms |
1R01CA281932-01A1 |
|
|